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Zusammenfassung
Das Molekül Vinkulin überträgt mechanische Kräfte in Integrin-basierten Adhäsionsstruk-
turen und verbindet dadurch das Aktinzytoskelett mit Talin. Eine muskelspezifische Spleiß-
variante namens Metavinkulin, die sich von Vinkulin durch einen 68 Aminosäuren langen
Einschub in der Schwanzdomäne unterscheidet, wurde mit Kardiomyopathien in men-
schlichen Patienten in Verbindung gebracht. Die Expression von Metavinkulin, kann zudem
durch externe Kräfte reguliert werden.
Um die Rolle beider Isoformen bei der Kraftübertragung an Adhäsionsstrukturen zu ver-
stehen, wurden sie mithilfe biochemischer und biophysikalischer Methoden verglichen.
Hierfür wurde eine Zelllinie verwendet, die weder Vinkulin noch Metavinkulin exprimiert.
Damit es möglich ist die Kräfte im Bereich von Pikonewton (pN), welche über diese Proteine
wirken, zu messen, wurden genetisch codierte Kraftsensoren etabliert, die auf dem Prinzip
des Förster-Resonanzenergietransfers (FRET) beruhen.
Die hierfür verwendeten Linkerpeptide sind durch Einzelmolekülmethoden kalibriert und
man kann das FRET-Signal in fokalen Adhäsionen lebender Zellen auswerten, indem man
die Lebensdauer der beteiligten Fluorophore bestimmt. Die Ergebnisse der vorliegenden
Studie zeigen, dass Metavinkulin einen Teil der Funktionen von Vinkulin übernehmen kann,
es aber Unterschiede bei den mechanischen Eigenschaften gibt: in Fokalen Adhäsionen
ist Metavinkulin immobilisierter als Vinkulin, es zeigt eine erhöhte Wechselwirkung mit
dem Protein Talin-1 und im Mittel wirken geringere Kräfte über Metavinkulin als über
Vinkulin.

Abstract
Vinculin is a force bearing molecule at integrin-mediated adhesion structures, which links
the F-actin cytoskeleton to talin. A muscle specific splice isoform called metavinculin,
which differs from vinculin by a 68 amino acid insert in the tail region, has been linked to
cardiomyopathies in human patients and shows force-dependent expression levels.
To understand their role in regulating mechanotransduction at focal adhesions, I directly
compared both isoforms in a cell line depleted of vinculin using a combination of biochemical
and biophysical techniques. In order to measure the piconewton (10−12N) (pN) forces acting
across these proteins, I established a variety of genetically encoded Förster resonance energy
transfer (FRET)-based tension sensors.
The linker peptides are calibrated by single molecule methods and I use fluorescence lifetime
imaging microscopy (FLIM) to evaluate the fluorescence signal from focal adhesions of
living cells. I find that metavinculin can compensate for the loss of vinculin but propagates
mechanical forces differently: it is more immobilized in focal adhesions (FAs) as compared
to vinculin, it displays stronger interaction with talin-1 and metavinculin bears lower forces
per molecule.
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1 Biological background
1.1 Motivation
Mechanical forces and even their absence shape the human body: extensive physical exercise
leads to muscle hypertrophy while exposure to zero-gravity results in muscle atrophy and
osteoporosis. While bodybuilders or astronauts consciously expose themselves to extreme
mechanical loads, many patients suffer from diseases caused by defective responses of
their body to normal mechanical stimuli [1]. One prominent example are heart diseases,
e.g. dilative and hypertrophic cardiomyopathies [2], which can result from defective
mechanotransduction across the integrin-talin-vinculin linkage [3].
Here, I present a study which analyzes the role of the focal adhesion (FA) protein vinculin
and its muscle specific splice variant metavinculin. Mutations in metavinculin [4–7] and
alterations of the vinculin or metavinculin expression levels [8, 9] have been linked to
cardiomyopathies in human patients.
Recently, Förster resonance energy transfer (FRET)-based genetically engineered biosensors
made it possible to directly measure forces in the piconewton (10−12N) (pN) range across
these proteins in living cells [10]. The study presented here combines these so-called tension
sensors with traction force microscopy (TFM), ultracentrifugation assays, cell stretching,
micropatterning, fluorescence recovery after photobleaching (FRAP), and biochemical analy-
sis methods, like mass spectrometry or Western blotting, to describe differences between
vinculin and metavinculin and unravel their role in mechanotransduction at integrin-based
adhesions.
1
1.2 Force transduction at cellular adhesion sites
1.2 Force transduction at cellular adhesion sites
1.2.1 Molecular mechanotransduction and mechanosensing
Cells can convert mechanical stimuli into biochemical signals to regulate e.g. adhesion,
migration, proliferation and differentiation [11]. Examples for such stimuli include substrate
rigidity, shear flow, gravitational pressure or contractile forces [12]. While concepts from
physics such as elasticity, strain, viscosity, shear stress, and tension are well-defined, the
nomenclature of mechanobiology is ambiguos. Vocabulary like sensing, feeling or touching,
which originally refers to processes of the mammalian somatosensory system, is often
used to describe mechanotransductory processes in non-neuronal cells. To enable in-depth
discussion some central terms will be clarified in the appendix (section 11), for further
reading please refer to [13–16].
Mechanotransductory processes range over multiple time-scales from seconds to weeks or
even years and occur on the molecular, single-cell as well as on tissue level (Fig. 1.3 B).
Compared to the speed of purely biochemical signaling which is limited by diffusion rates,
mechanotransduction enables rapid (< 0.3 s) propagation of signals, e.g. activation of the
kinase Src, across the pre-stressed cytoskeleton [17]. Early observations indicated that the
composition of the extracellular matrix (ECM) can regulate gene expression [18] and later it
was demonstrated that substrate rigidity can drive stem cell lineage differentiation [19].
One major goal of mechanobiology is to identify mechanosensors which change their
conformation, binding affinities or post-translational modification (e.g. phosphorylation) as
a response to mechanical stimuli. The most prominent examples identified so far are talin
and vinculin at cell-matrix adhesions and cadherins at cell-cell junctions [10, 20, 21].
1.2.2 Integrin-mediated adhesions to the ECM
Adhesion to surrounding matrix proteins is one of the prerequisite for the formation of
multicellular organisms and tissue structures. In early interference microscopy observations,
dark regions closer to the substrate were described as ’feet’ of the cell [22]. Today, it is well
established that clustering of the transmembrane proteins α- and β-integrin at those sites
generates a physical link to the substrate [23]. There are 18 α and 8 β-integrins in mammals,
which can be combined to 24 different obligate heterodimers in a cell-type dependent
fashion. The intracellular C-terminal domains of integrins act as a scaffold for up to 300
other adhesion and signaling proteins which indirectly or directly bind to them to form
the so-called adhesome [24]. Based on their morphology, location, and protein composition
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adhesions are classified as focal complex (FX), FA or fibrillar adhesion and are divided into
stable and transient structures. During cell migration on two-dimensional surfaces nascent
adhesions of about 0.5 µm2 form at the cell periphery and mature into streak-like strucures
with a length of 2− 10 µm (Fig. 1.1 A & 1.2 A).
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Figure 1.1: Composition of FAs A. Immunostaining of a fibroblast on fibronectin (FN) coated glass slide.
Focal adhesion proteins vinculin (green) and paxillin (yellow) co-localize with the F-actin cytoskeleton (red)
at adhesion structures. FX can be observed as punctae at the cell periphery, while mature FA form at the
end-points of stress fibers. B. New superresolution techniques like iPALM lead to a better understanding of
the 3D organisation of FA. Illustration of the current model for different layers from [25]: FA are divided into
an integrin signaling layer (ISL) at 0− 30nm above the plasma membrane, force transduction layer (FTL) at
30− 60nm and the actin regulatory layer (ARL) at > 60nm.
The maturation of adhesions is depends on tension generated by the acto-myosin network.
Both, inhibition of Rho-associated protein kinase (ROCK) and truncation of the talin rod
domain, lead to small residual adhesion structures with reduced levels of vinculin [20].
Superresolution techniques, namely three-dimensional interferometric photoactivation local-
ization microscopy (iPALM), revealed the nanoscale organization of FA and its subdivision
into integrin signaling layer (ISL at 0− 30 nm above the plasma membrane), force trans-
duction layer (FTL at 30− 60 nm) and actin regulatory layer (ARL > 60 nm) [25] (Fig. 1.1
B).
A central view which has evolved during the last years and influences our understanding
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of FA structure and function is the molecular clutch hypothesis [25]. Proteins within FAs
engage with the retrograde actin flow, leading to the generation of mechanical tension
within FAs and traction forces at the outside of cells [27]. This process is very dynamic and
still poorly understood. However, it has been recognized that FA clutches crucially depend
on protein kinetics: while slip-bonds shorten FA lifetime, catch-bonds strengthen under
force and lead to stabilization [28] (Fig. 1.2 B).
1.2.3 The integrin-talin-actin linkage
Activation of integrins, through binding of the talin phosphotyrosine binding (PTB) domain
to the cytoplasmic tail of β-integrin, is important for both inside-out, and outside-in signaling
at FAs [29]. Binding of the talin tail region with the F-actin cytoskeleton provides a link
necessary for cellular rigidity sensing and direct force transduction, which is isoform specific
and regulated by vinculin [20, 30]. Functional integrin-talin-actin linkage is a pre-requisite
for the proper maturation of FA [20].
Both, talin-1 and talin-2 consist of an N-terminal globular head containing a 4.1 protein,
ezrin, radixin, moesin (FERM) domain (47 kDa), and a C-terminal rod (220 kDa) consisting
of 13 helical bundles (R1-R13), which can unfold under force to expose up to 11 putative
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Figure 1.2: Engagement of actin flow at adhesion sites A. Filamentous actin can form stress fibers or parallel
and cross-linked filaments in different cell compartments. At FAs actin retrograde flow is slowed down and
stress fibers are linked to the substrate. The protruding edge of the cell consists of the lamellipodium and
filopodia which form extended membrane protrusions [26]. B. Proposed mechanism of a molecular clutch:
actin polymerization takes place in the lamella where transmembrane protein integrin provides a tether to the
ECM (I). A multitude of molecular clutch proteins (e.g. vinculin, talin, α-actinin) bind to either integrins or the
cytoskeleton which both serve as a scaffold for multiple FA proteins (II). Upon engagement the F-actin flow
can be locked, leading to forward protrusion which is balanced by traction force on the surface (III). Image
and model taken from [25].
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vinculin binding sites (VBSs) (Fig. 1.5 C) [31]. Data from atomic force microscopy (AFM)
studies, in vitro reconstitution and structural mutations showed that actomyosin-generated
force across the talin rod domain unfurls these cryptic VBSs in a sequential manner (Fig. 1.3
A & 1.5), making it the most prominent molecular strain gauge at FA sites [30, 32, 33].
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Figure 1.3: Extension of molecular bonds under force A. Talin is the most prominent example of a FA
mechanosensor which opens up vinculin binding sites under force. Exceeding a threshold force leads to
breaking of the bond and results in disruption of vinculin binding helices (taken from [34]). B. Mechanotrans-
duction ocurrs on various time- (µs to years) and length-scales (nm to m). Most processes follow a scaling law
with fast events like change in protein conformation on short time and length-scales whereas other processes
(e.g. organ growth or development of pathologies) require longer times and manifest in larger size. This is not
a universal law as for example somatosensory signaling which is very fast can expand over meters, whereas
modulation of epigenetic factors in the genome is a molecular process which can take years.
1.3 Biological function of vinculin and metavinculin
Since its discovery in 1979 [35] vinculin has been ascribed roles ranging from tumour progres-
sion [36] and apoptosis [37] to stem-cell differentiation [38], local mRNA translation [39, 40],
and facilitation of bacterial entry [41]. Additional to the ubiquitously expressed vinculin, a
splice isoform called metavinculin is expressed in smooth (30− 40% of total protein) and
skeletal muscle (5− 25% of total protein) with expression levels depending on muscle type,
differentiation state and mechanical stimulation of tissue (Tab. 1.1) [42–44]. Here, I want
to focus on vinculin’s importance for mechanotransduction at integrin-mediated adhesion
structures where it provides a force-bearing linkage to the actin cytoskeleton [10] and com-
pare it to its splice variant metavinculin. While there is an extensive literature on vinculin
function and regulation [30, 45, 46], only few comparative studies about metavinculin exist
[44, 47, 48].
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1.3.1 Structure and regulation of vinculin and metavinculin
Full-length vinculin contains 1066 aa, has a molecular mass of 117 kDa and consists of five
domains (D1-D5) which are arranged into a globular head (D1-D4) and a tail domain (D5
or Vt, consisting of 5 amphipathic α-helices H1-H5) linked by a proline-rich strap [49–51]
(Fig. 1.4 A-C). Alternative splicing of Exon 19 generates a 68 aa insert in the tail region
at aa 883-884, which is flanked by a KWSSK motif, resulting in the isoform metavinculin
[52, 53]. The C-terminal half (aa 29-68) of the metavinculin insert, contains the only tyrosine
and is conserved across all analyzed vertebrate species [53]. Crystal structures revealed that
the metavinculin insert replaces the first α-helix H1 of the vinculin tail domain (Vt) and its
N-terminal extended coil by a new α-helix H1’, while helices H2-H5 remain unchanged [54]
(Fig. 1.4 D-F).
D1 D2
D3D4 Vt
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D1 D2
D3D4
Vt
H1
H5H2
H3
H4
B C
H1
H2
H1’
H2
D E F
C  -­  terminus
N  -­  terminus
C  -­  terminus
N  -­  terminus
Figure 1.4: Structure and regulation of vinculin A. Crystal structure of vinculin according to [49] B. Schematic
illustration of vinculin head (Vh: D1-D5) and tail (Vt) domains in the closed conformation C. Release of
head-tail interaction (HTI) leads to an open conformation of vinculin. The tail domain consists of 5 helices
(H1-H5) which are connected by flexible linker regions. Image is based on the crystal structure from [55] D.
Overlay of crystal structures from Vt (residues 879–915; PDB entry 1rkE) and metavinculin tail domain (MVt)
(residues 947–983; cyan). Helices of the Vt are color-coded as shown in C. [54]. E. Domains H1 and H2 of
vinculin tail F. The 68 amino acids (aa) long insert of metavinculin replaces the helix H1 by a longer helix H1’.
The strap region is elongated.
Association between head and tail domain of vinculin which is mediated by two high affinity
interactions (D1-Vt with Kd = 10−7M, D4-Vt with Kd = 10−2M), leads to an inactive or
autoinhibited state [56] (Fig. 1.4 B). It is not clear whether one or two binding partners
are necessary to release this head-tail interaction (HTI) (Fig. 1.4 C) but its importance
for vinculin localization and function has been demonstrated using various mutants (e.g.
head-tail interaction (HTI) (N773A/E775A) and T12 (D974/K975/R976/R978A)) and a
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FRET activation sensor [25, 36, 57]. The affinity of the vinculin head domain (Vh) for MVt
(Kd = 3 · 10−7M) is significantly less than for Vt (Kd = 5 · 10−8M) [44].
Early studies suggested that both vinculin and metavinculin form complexes of up to six
molecules [50]. More than 30 years later it is still not clear whether and how oligomerization
is needed for cellular functions of vinculin. Multiple studies state the importance of vinculin
dimerization for F-actin bundling and suggested that metavinculin has to form a heterodimer
with vinculin in order to be activated [44, 54]. Upon binding to the lipid phosphatidylinositol
4,5-bisphosphate (PIP2) vinculin seems to undergo a conformational change which promotes
oligomerization of three tail molecules [55].
Phosphorylation has been identified as one of the key mechanisms in the regulation of
vinculin localization, activation and function. Abelson (Abl) kinase phosphorylates vinculin
at position Y822 specifically in cell-cell contacts after application of force to E-cadherin [58].
Tyrosine phosphorylation at position Y100 and Y1065 is regulated by the Src kinase and
has been shown to affect generation of traction force, cell spreading [59, 60] and is needed
for contraction of smooth muscle cells [61]. Serine phosphorylation of S1033 and S1045
is mediated by the protein kinase C alpha (PKCα) kinase and also has been implicated in
vinculin activation and regulation of force transmission [62]. A recent study compares the
effects of phosphorylation and HTI mutants on strain energy, cellular stiffness and turnover
rates [63].
1.3.2 Major binding and interaction partners of vinculin and
metavinculin
Vinculin serves as a scaffold or adapter protein [64] at FA sites and can recruit other proteins
in a force-dependent manner [65]. The head region of vinculin binds to talin, α-actinin,
PKCα, Shigella invasin (IpaA), α- and β-catenin; proteins of the vinexin familiy, vasodilator-
stimulated phosphoprotein (VASP), Arp2/3 and ponsin bind to the linker region and the
vinculin tail binds paxillin, F-actin and PIP2 [66] (Fig. 1.5 A). Metavinculin shows higher
affinity than vinculin for the RNA-binding protein Raver-1, which it can bind even in its
closed state [40]. Interactions of MVt with F-actin and PIP2 have been studied in vitro [44],
but many details about metavinculin binding partners in the cell are lacking.
Vinculin binding to talin is highly regulated and isoform specific. The talin-1 rod contains at
least 11 cryptic vinculin binding sites which open up after stretch-induced conformational
changes [31, 32, 67, 68] and keep talin in a vertically extended conformation in FAs [25]
(Fig. 1.5 B). Recent data from our lab revealed that mechanically engaged vinculin increases
7
1.3 Biological function of vinculin and metavinculin
force across talin and showed that only talin-2 can recruit vinculin in the absence of F-actin
binding [20].
Interaction with PIP2 is supposed to regulate oligomerization properties of vinculin and
activation of metavinculin [44, 48, 69]. Lipid binding mutants showed severe defects in cell
spreading, adhesion turnover and motility [48, 55, 69].
1.3.3 Role of vinculin and metavinculin during actin bundling and
polymerization
In the absence of an activating agent, vinculin does not co-sediment with actin [70] as the
binding site is masked by head-tail interaction (HTI) [71]. Upon activation it appears to
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Figure 1.5: Interaction partners of vinculin and metavinculin A. Interaction partners of vinculin which bind
to head (blue), linker (green), and tail (orange) region of vinculin. The gray insert shows proteins which
interact indirectly with vinculin. Inspired by [64] B. Model of talin stabilization by vinculin. Actin (red)
binding to the talin rod unfurls domains R2-R3 which contain vinculin binding sites. Domains of the talin rod
which change their conformation upon actin binding are depicted in yellow. Vinculin (green) is activated upon
binding to talin. Further recruitment of actin leads to incorporation of multiple vinculin molecules which lock
talin in an unfolded state and stabilize it in FA. Image is based on the model from [30] C. Position of actin and
vinculin binding sites (ABS in red, VBS in green) in the talin rod domain according to [30]. Most binding sites
are masked in the inactive talin and unfold after application of pN forces.
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undergo a complex interaction: it was shown to promote actin nucleation [72], barbed end
capping [73], but also de-polymerization [74] as well as actin bundling via its C-terminal
hairpin (aa 1061-1066) [75, 76].
The original model of Janssen et al. [77] which suggested binding of actin to helices H2 and
H3 of Vt has been challenged by the discovery of new actin-binding deficiency mutations
(I997A and V1001A) located on helix H4 [78] (Fig. 1.6 A,B). Actin speckle microscopy
showed that these mutations were not able to slow down actin retrograde flow at FA [27].
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Figure 1.6: Interaction of (meta)vinculin with actin A. Janssen model: 3D reconstruction of actin filaments
(gray) decorated with Vt (red) (rotated by 90◦, 2 nm resolution) from [77] B. Three different in vitro experiments
marking the different levels of MVt and Vt interaction with F-actin. Fluorescence microscopic analysis revealed
bundling activity of Vt and showed finer networks for a mixture of actin and MVt [75]. The enhanced precision
of eletron microscopy suggested a role for MVt [79] in severing actin filaments, however, real-time total internal
reflection microscopy (TIRF) revealed a more complicated mechanism in which differences in actin stability
and persistence length between Vt and MVt tune actin interaction [80]. C. Vinculin tail (red) binding to actin
monomers (upper: gray, lower: green). D. Proposed actin binding surface (red) in the vinculin tail domain
(gray) which can be disrupted using point mutations V1001A or I997A. Crystal structures from [77, 78].
Our understanding of how the MVt insert affects F-actin organization has been growing
with the introduction of new experimental techniques (Fig. 1.6 B). Early co-sedimentation
studies observed a decreased F-actin bundling activity for MVt constructs in vitro, leading to
highly viscous F-actin networks [75]. More recent electron microscopy (EM) studies claimed
that MVt can sever actin filaments in a process supposedly mediated by a domain with 47%
sequence homology to the severing protein gelsolin [79]. This view has now been challenged
by the observation, that MVt does not possess a strong severing activity in real-time TIRF
experiments [80]. Indeed, it seems that MVt merely tunes the flexibility of actin filaments
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which makes them more susceptible to breakage [80]. How vinculin and metavinculin
interact with actin in the crowded cytoplasm of living cells remains unknown.
1.3.4 Recruitment to FAs and regulation of force transduction
According to our definition (Tab. 1.2.1) vinculin is both, a mechanosensor and a mechan-
otransducer, which is involved in passive as well as active mechanotransduction. Knockout
of vinculin leads to defective cell spreading, but increases speed of random migration,
consistent with the idea that vinculin acts as a molecular clutch to slow down the actin
retrograde flow at FAs [27].
Interestingly, cells depleted of vinculin still assemble large FAs and expression of a Vh
construct even increases their size. While some experiments show, that loss of vinculin leads
to 20− 30% reduction in traction force [27, 81], others observe similar traction levels for
vinculin depleted cells [38].
The recruitment of full-length vinculin depends on tension generated by the actomyosin
network. Inhibition of ROCK (e.g. by Y-27632) leads to disappearance of vinculin from FAs
while a Vh construct remains in the small adhesion sites and even stabilizes talin [65]. Some
proteins like vinexin are recruited to adhesion sites only upon vinculin activation [57].
With the development of a new genetically encoded vinculin tension sensor (TS) [10] it
is now possible to map distribution of FRET efficiencies and relate them to cell shape,
FA morphology, FA dynamics, traction force and the geometry of individual stress fibers
[82–84]. The emerging picture shows complex multi-modal relationships between these
quantities, which are explained by computational models [83] and one study even proposes
compression of the vinculin TS [84]. However, due to the high noise level of all experiments
which determine FRET ratios from intensity-based methods, special care has to be taken
with the interpretation of these results [82].
1.3.5 Tissue specific localization and regulation of metavinculin
Metavinculin is expressed in muscle tissue and has been shown to be involved in myogenesis
[42]. However, correlations between metavinculin to vinculin ratio and muscle type, differ-
entiation state or muscle load are complex (Tab. 1.1). Quantification of relative amounts
of metavinculin in human tissue showed that metavinculin is highest in smooth and fast
skeletal muscle (20− 30%) and low in slow skeletal muscle [85, 86]. More recent studies
suggest, that this could be directly linked to different fiber types: positive metavinculin
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Muscle type Method Vinculin Metavinculin Ref.
rat soleus (slow skeletal muscle) hind-limb suspension + de novo
expression
[88]
rat soleus (slow skeletal muscle) FAK overexpression unchanged + + [88]
rat EDL (fast skeletal muscle) hind-limb suspension + unchanged [88]
human vastus lateralis bed rest unchanged + [89]
human vastus lateralis resistance training unchanged + + [89]
mouse tibialis anterior chronic stimulation + + - [90]
mouse tibialis anterior denervation + + - [90]
lamb LTL sainfoin vs. unchanged + + [91]
alfalfa feeding
human myometrium pregnant vs. total vinculin doubled [92]
non-pregnant
Table 1.1: (Meta)vinculin expression in muscle
staining is observed in fast glycolytic muscle fibers, while it is absent from slow oxidative
and fast oxidative glycolitic fibers [87].
During development the amount of metavinculin in human aortic smooth muscle cell (SMC)
increases about 7-fold from a 9− 10 weeks old fetus to a 6 month old child and is rapidly
lost when aorta SMC are taken into culture [53]. Furthermore, it has been shown, that
metavinculin levels can be altered by muscle loading in humans (Fig. 1.7 D) [89], hindlimb
suspension in mice [88] and even change of food source in lambs [91]. De novo expression
of metavinculin in rat soleus muscle after hind-limb suspension has been explained by
a possible switch from slow to fast muscle type [88]. Interestingly, overexpressing focal
adhesion kinase (FAK) in soleus muscle fibers lead to a significant increase of metavinculin,
but left vinculin levels unchanged [93].
1.3.6 Involvment of vinculin and metavinculin in physiology and disease
Homozygous knockout of vinculin is embryonically lethal at E10.5 due to severe heart
defects [94]. Heterozygous vinculin knockout [95] and cardiac-myocyte specific excision of
the vinculin gene [8] both lead to heart failures. The deletion of exon 20 in a mouse model,
results in actin binding deficiency [96].
Overexpression of vinculin in Drosophila melanogaster induces cardiac remodeling and
increased life-span by 150%, indicating a role in maintaining healthy heart structure [97]. A
more regular myofilament lattice induced by vinculin overexpression is thought to reinforce
the cortical cytoskeleton (Fig. 1.7 A,B). On the other hand, reduced vinculin expression
is observed at intercalated disks during obstructive hypertrophic cardiomyopathy (HCM)
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in the human heart and in atherosclerotic tissue [4, 98]. Even before the onset of dilated
cardiomyopathy (DCM) vinculin deficient heart tissue showed an increased lattice spacing
of myofilament cross-sections and for vinc+/− myocytes a significant decrease of stiffness
was observed [9].
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Figure 1.7: Expression of (meta)vinculin in heart, vasculature and muscle tissue A. Cardiac myocyte struc-
ture showing position of cell-cell junctions called intercalated discs and cell-matrix junctions which are referred
to as costameres. B. Proposed model for vinculin in maintaining cytoskeletal stability in ageing humans
or animals. Myofibrils are reordered upon overexpression of vinculin into a more symmetric myofilament
lattice, which can withstand higher forces [97]. C. With increasing severity of disease defined by the atheroma
score, metavinculin content of atheriosclerotic lesions drops. Data taken from [98] D. Change of vinculin and
metavinculin content in human vastus lateralis before and after bedrest for 34 days [89].
To date, two missense mutations in the metavinculin insert (A934V, R975W) and one aa
deletion (L954) have been found in patients with both HCM and DCM; two point mutation
are common to both vinculin and metavinculin (L277M, K815R) [4–7] and metavinculin
deficiency was linked to idiopathic DCM [99]. Besides cardiomyopathies, metavinculin also
might be involved in atherosclerosis as expression levels correlate with severity of plaque
formation (Fig. 1.7 C) [85, 98].
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1.4 Summary of biological background
FAs provide a major hub for signaling, generate mechanical linkages between the cell and
its surrounding and at the same time anchor and regulate the cytoskeleton. Vinculin is only
one, albeit a very important, player in FA dynamics involved in shaping local interactions,
e.g. with talin or F-actin, as well as regulating the function of organs like the heart. The 68
aa muscle-specific metavinculin insert in the tail domain has already been described more
than 35 years ago and experimental evidence for its relevance is accumulating, while little
progress has been made in understanding metavinculin’s molecular function. I presented
existing findings on metavinculin’s role in F-actin bundling and disease.
Understanding isoform-dependent regulation of proteins provides a more general insight
into how biological structures deal with varying mechanical stimuli and force ranges in
different tissues. It is beyond the scope of this thesis to link molecular function to tissue
specific gene expression, however, it should be kept in mind that direct pathways between
mechanotransduction at FA and signaling to the nucleus exist.
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2 Biophysical and theoretical background
The challenge to perform biophysical experiments in living cells can be divided into
two parts: providing reproducible, well-defined mechanical or biochemical stimuli and
- even more intricate - developing methods for a reliable read-out of parameters. These
methods should minimally disturb the system and be robust enough to generate significant
results in the presence of biological noise. Linking measured values to physical quantities
requires a theoretical description of biological properties and relies on additional calibration
experiments.
Here, I present a biosensor technology to measure pN forces across single proteins and
introduce the theoretical background which is important for its application, but also for
the general description of mechanobiological properties of single cells. On the single
protein level, statistical theories which account for the occupation of different states, like the
worm-like chain (WLC) model, need to be employed. We use the fact, that this nanoscale
description of protein conformation is an adequate input for the Förster equation and can
be used for the description of single-molecule calibration experiments of our biosensors.
On the other hand, biophysical experiments like TFM, cell stretching or the use of mi-
cropatterns and elastic substrates are described. Elasticity theory is a powerful tool which
can be used to quantify both, the deformation of flexible substrates and of the whole cell
or the cytoskeleton, under the assumption of small linear deformations. Together, these
experimental methods and the read-out by FRET-based TSs provide a framework for the
comparative study of vinculin and metavinculin.
2.1 Genetically encoded FRET-based tension sensors
A current review lists the generation of FRET-based protein stretch sensors as one of the
milestones in the history of mechanotransduction research [16]. Here, I want to discuss
their implementation for live cell measurements in FA proteins and show both, advantages
and limitations, of their evaluation with time-correlated single photon counting (TCSPC)-
fluorescence lifetime imaging microscopy (FLIM).
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2.1.1 Principle of FRET measurements
The rate of FRET between two light-sensitive molecules (e.g. organic dyes, fluorophores)
depends on their separation distance r, orientation κ and the overlap integral J between
the normalized donor fluorescence intensity FD and the exctinction coefficient εA(λ) of
the acceptor [100]. Transfer of energy from the donor molecule D to the acceptor A is
non-radiative and its efficiency can be calculated as
E =
R60
r6 + R60
(2.1)
with the Förster distance R0 which is constant for a given D − A pair and given as
R60 =
0.9 ln(10)
128π5NA
κ2QD
n4
￿ ∞
0
FD(λ)εA(λ)λ4dλ (2.2)
with quantum yield QD, refractive index n and Avogadro’s number NA [100]. For exper-
imental measurements the relation between FRET efficiency E and donor intensity I or
lifetime τ in presence (IDA, τDA) or absence (ID, τD) of the acceptor is often described as
E = 1− IDA
ID
(2.3)
E = 1− τDA
τD
(2.4)
This simplification is only true under the assumption of a fixed distance between D and
A. For this study the FRET-pairs venus/monomeric Cherry (mCherry) and genetically
truncated version of yellow fluorescent protein (YFP) (YPet(s))/mCherry with a Förster
radius of approximately 5.8 nm were used.
2.2 Calibration of linker peptides
A tension sensor module consists of a linker peptide which is flanked by two fluorophores
or organic dye molecules at a distance of 2 − 5 nm, leading to a high initial FRET (Fig. 2.1
A). Upon stretch the dye molecules are separated and FRET efficiency decreases. Calibration
of the linker peptide or even the whole TS module via single-molecule measurements or
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theoretical modeling defines a direct relationship between the applied force in the pN range
and the extension of the linker in nm or the FRET efficiency E [20].
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Figure 2.1: Calibration of peptides for tension sensor measurements A. Illustration of TS modules used for
internal sensors and zero-force control as depicted in [101] B. Two laser traps are used to calibrate the villin
headpiece peptide (HP35) linker peptide. DNA was attached on each site of the purified HP35 construct,
which consists of two fluorophores (YPet(s) and mCherry)and a linker, using cysteins. Figure taken from [20].
C. Curve of FRET efficiency vs. force for modelled curves of HP35 and stable. Fits were performed using a
WLC model with three states. D. Contributions of unfolded (black), folded (black dashed) and semi-folded
gray dashed) states to the force-extension curve of the HP35 linker peptide. The average protein extension as a
function of force is depicted in red. E. Probability distribution for the occupation of different states depending
on force. B. - E. Taken from [20].
For this study two calibrated peptides have been used: an amino-acid motif from the spider
silk protein flagelliform consisting of eight GPGGA repeats (F40) being sensitive to forces
in the range of 1− 6 pN [10] and a villin headpiece peptide (HP35) which can be tuned
by a double point mutation (HP35st) between force ranges of 6− 8 pN or 9− 11 pN [20].
While the flagelliform linker had been calibrated via fluorescence force spectroscopy using
two organic dyes (Cy3 and Cy5) to determine the force-FRET efficiency relation [10], the
force spectroscopy for the HP35 was performed using the original fluorophores YPet(s) and
mCherry and two laser traps for direct measurement of the extension length [20].
Force sensing elements which have been used by other groups include α-helices [102],
spectrin repeats [102], and PEG polymers tethered to surfaces [103]. For a complete review
please refer to [101].
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2.2.1 Theoretical description of linker peptides
The reaction of an entropic spring to an external force F can be modeled by a basic WLC
model which assumes a rigid behavior at short distance and flexible behavior at length
scales larger than the persistence length lp. To maximize its entropy a polymer peptide will
maintain a conformation with an end-to-end distance significantly smaller than the contour
length. We can write this down as Hamiltonian operators for the entropic part and the
external force F
H = Hentropic +Hexternal = 12 kBT
￿ l0
0
lp ·
￿
∂2r(s)
∂s2
￿
− xF (2.5)
An interpolation formula which states that forces are in the order of F ∼ kBT/lp can be
used as a fit for experimentally derived force-extension relations [104]
F(x, lp) =
kBT
lp
￿
1
4(1− x/lp)2 −
1
4
+
x
lp
￿
(2.6)
With the Förster radius and the fluorophore separation distance the mean FRET efficiency E
can be linked to a given force F. Based on experimentally observed force-extension curves a
model of the distribution of single folding states can be derived. For n states it is given in a
general form as
EFRET(F) =
n
∑
i=1
EFRET
￿
xi(F)
￿ · pi(F) (2.7)
with the probability pi(F) for a given state i with extension xi(F) (note: ∑i pi(F) = 1). The
most simple case is a direct transition between a completely folded and unfolded state,
however, the assumption of intermediate states (e.g. folding of sub-domains) might be
necessary to fully explain protein behavior. For calibration measurements of the linker
peptide HP35 a 3-state WLC model with folded, unfolded and partially folded states
accurately reproduces experimental data (Fig. 2.1 D,E) [20].
2.2.2 Introduction of tension sensor modules into the protein of interest
The calibrated tension sensor module can be introduced into a protein of interest and
analyzed in vitro, in living cells or even inside living organisms [101]. To access whether
a certain protein bears mechanical force in a specific cellular context or upon stimulation
by external forces, a suitable insertion site, which maintains protein functionality, has to be
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limitation examples
structural
FRET upon conformational change, alteration of
domain structure, intermolecular FRET, oligomerization,
cleavage of fluorophores, incomplete folding or
labeling
biological
impaired localization, change in binding partners,
altered dynamics, too high or too low expression level,
cell cycle arrest
photophysical
variable chromophore orientation, limitations by shot noise
and signal-to-noise ratio, effects of pH or temperature
dependence
Table 2.1: Factors disturbing live cell tension sensor experiments
determined. Usually unstructured regions between protein domains, like the proline-rich
linker in vinculin, are well suited for TS module insertion.
Besides structural integrity, maintenance of biological function is crucial and has to be
well tested. Rescue of cells with a TS construct after knockout of the target protein is
recommended to avoid effects of overexpression and test biological function. Table 2.1 and
publications from our group [10, 101, 105] list additional potential confounding factors,
additional control experiments need to be tailored to each individual system and protein of
interest.
2.2.3 Live cell measurements using TCSPC-FLIM
Confocal laser scanning microscopes (LSMs) can be used to evaluate fluorescence signal
from fluorophores inside living cells. As discussed before, FRET is expressed as a change in
donor intensity or lifetime (eq. 2.4). Both quantities are used to determine FRET efficiency in
biological samples: intensities can be mapped by approaches like ratiometric FRET, donor-
or acceptor photobleaching, whereas lifetimes are determined by FLIM [100].
In contrast to intensity-based methods, FLIM is independent of fluorophore concentration
over a wide range. Donor and acceptor are always linked in TS constructs, however, not all
fluorophores might be completely folded. While unfolded donor molecules do not appear in
the measurement, incomplete folding of the acceptor leads to measurement of donor lifetime
only. FLIM can be measured in time or frequency domain by exciting the sample either with
single laser pulses shorter than the lifetime (e.g. 10− 100 f s) or intensity modulated light
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(frequency domain FLIM) [106]. Photon arrival times are measured by a TCSPC detector
with parallel photomultiplier (PMT) detectors.
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Figure 2.2: Measurement of FRET in living cells using TCSPC-FLIM A. Experimental photon count curves
from lifetime measurements of donor fluorophore (venus) and TS construct (F40). Both curves were normalized
to maximum count. B. Mean lifetime over ten experiments, error bars indicate standard error of the mean
(SEM). A significant decrease in the lifetime of donor in presence of the acceptor can be seen in the TS
constrsuct. C. & D. Lifetime of donor and TS construct calculated as a function of position. Note that FLIM
measurements not depend on intensity and dim or bright areas fluorescence image yield the same values for
lifetime. All images taken from [105].
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2.3 Mechanical manipulation of the cellular environment
2.3.1 Linear elasticity theory in the context of TFM and cell stretching
Next, some general concepts from linear elasticity theory which are important for the inter-
pretation of both TFM and cell stretching experiments will be introduced. We only consider
isotropic, incompressible elastic materials (Poisson ratio ν ≈ 0.45 for polyacrylamide (PAA)
and ν ≈ 0.5 for PDMS), which retain linear behavior as long as small deformations ε￿ 1
are applied. For well-spread adherent cells, e.g. fibroblasts on FN coated PAA substrates,
algorithms which assume an infinitely large thickness and neglect forces normal to the
surface can be employed [107]. The displacement vector field u = x￿ − x describes the
transformation between the initial state x and the deformed state x￿, where x is a vector
with components (x, y, z), refered to by indices i, j, k. As discussed above, for small strains a
linearization applies and the strain tensor ε can be written in component notation as [108]
εij =
1
2
￿
∂ui
∂xj
+
∂uj
∂xi
￿
. (2.8)
Each component of the stress tensor σij can be written as (δij: Kronecker delta)
σij =
E
1+ ν
￿
εij +
ν
1− 2νεkkδij
￿
. (2.9)
The relationship between the stress tensor σ and the strain tensor ε depends on the material
properties Poisson ratio ν = − εyyεxx = − εzzεxx and Young’s modulus E = σε . While the Poisson
ratio describes the coupling between different dimensions, the Young’s modulus quantifies
the substrate stiffness and is given in units of Pascal (1 Pa = 1 Nm2 ); the shear modulus
G can be calculated from the Young’s modulus E as G = 12
E
1+ν . The elastic modulus E
scales with the length-scale of interactions as 1r2 , leading to large differences in its value for
different materials (diamond ≈ TPa, rubber ≈ MPa, cells ≈ 10 kPa) [109]. In the context
of biomechanics of the cytoskeleton or the ECM most interactions are in the range of
10− 500 nm and typical elastic moduli are between 0.1− 50 kPa. To calibrate experimental
systems the position of fiducial markers (e.g. fluorescent beads) or regular patterns is
tracked after the application of known forces [110]. Substrate stiffness can be measured via
AFM, film stretching under gravity or bulk rheology [111].
21
2.3 Mechanical manipulation of the cellular environment
2.3.2 Analysis of cellular traction forces
Seeding of cells on two-dimensional elastic substrates generates deformations, which can
be visualized by tracking the movement of embedded fluorescent beads [112] (Fig. 2.3 B).
Other methods to map cellular traction force include measurements of substrate wrinkling,
and micropillar deflection [34, 113, 114] (Fig. 2.3 A,C). Its is also possible to estimate the
force generated by integrin via the extension of TS tethered to the surface [115] (Fig. 2.3
D).
Areas of large traction coincide with positions of FA and forces are positively correlated with
FA size within single cells [113, 114]. Typical stresses per FA across different cell types are
in the range of 1− 5 nN/µm2 [116]. Interestingly, increasing FA size does not automatically
strengthen attachments, as higher actin flow rates are associated with FA enlargment [27].
Recent experiments show that spread area alone regulates tension of adherent cells and
claim an independence of cell geometry or total number of FA [117].
C DBA
vv mergedisplacement
E F
MV
Figure 2.3: TFM and micropatterning A.-D.: Different approaches to measure cellullar traction forces [108]:
A. wrinkling of the substrate, B. tracking of beads embedded in soft substrates, C. micropillar arrays or D.
tension sensor constructs tethered to the surface. E. Fibroblast with vinculin-venus (VV) on cross shaped of
micropatterns of 40 µm width on 8 kPa PAA, red arrow indicate traction field calculated by Fourier transform
traction cytometry (FTTC) F. Vinculin knockout fibroblast with metavinculin-venus (MV) stained FA on parallel
pattern of 5 µm spacing and 1 µm width, scale bar 10 µm.
2.3.3 Modulation of substrate stiffness and micropatterning
Cell morphology can be influenced by choice of ECM coating ligand (e.g. FN, collagen,
poly-L-lysine (PLL)), substrate stiffness and micropatterning approaches which restrict the
accessible surface. Micropattern geometries use lines or dots, which restrict FA position, but
allow normal cell spreading or regularly shaped areas (e.g. circles, squares, triangles) that
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restrict spreading and allow free FA formation, as well as combinations of both [118]. Cells
will only be able to adhere when integrin cluster spacing is not exceeding a threshold of
50− 100 nm [119].
Stiffness can experimentally be tuned between 100 Pa and 109 Pa on glass surfaces [111].
However, the typical threshold for efficient spreading is around 500 Pa, as many cell types
will not be able to generate sufficient forces to adhere on softer substrates and round up
[120, 121]. Some surface ligands like PLL allow cells to adhere to a substrate without
spreading and mimic behavior on soft substrates. Rigidity sensing enables cells to follow
stiffness gradients in a process called durotaxis and can be regulated by expression of
different integrin subtypes or talin isoforms [20, 121].
A B
relaxed stretched
Figure 2.4: Stretching of cells on elastic substrates A. Schematic illustration of a uniaxial cell-stretcher
consisting of a polydimethylsiloxane (PDMS) chamber, which can be elongated using a motorized positioning
stage. Cells are seeded on top of the coated PDMS experience the stretch and reorient their shape and
cytoskeleton accordingly. Taken from [124] based on the original publication [110]. B. Reorientation of
fibroblasts seeded on FN coated PDMS (6 h of 10% stretch at 1.2Hz). Scale bar 40 µm, arrow indicates axis of
largest principal stretch. Image taken from [123].
2.3.4 Cell stretching
In the human body cells are constantly stretched and compressed as a result of muscle
activity or changes in hydrostatic pressure. Stretching is for example very prominent in
heart tissue or in myometrium during labor, where it can be described as clearly distinct
stretch and relaxation cycles with a defined frequency. To study the response of single
cells to external stretch, transparent flexible substrates are either deformed transiently or
stimulated periodically. Both, uniaxial and cyclic stretches are used to mimick naturally
occuring deformations (e.g. FlexCell or devices described in [110, 122]). Live cell imaging
and immunostaining can be used to quantify reorientation of the cytoskeleton and FAs,
following stress of different frequency or magnitude [110, 123]. Experimental data shows
that cell morphology follows changes in the actin cytoskeleton with a temporal delay and
maintains an angular orientation which can be described by theoretical modeling [110].
23
2.3 Mechanical manipulation of the cellular environment
One predicition was, that cells should orient their cytoskeleton towards the direction of
minimal strain, which can be calculated from the transversal shrinkage factor k = − εyyεxx
using the main components of the strain tensor ε which has already been defined in section
2.3.1 and can be experimentally measured as described in [110]. However, a recent study
shows that it is necessary to introduce an additional parameter which accounts for cell’s
elastic anisotropy [123]. Minimizing intercellular shear stress also seems to be important in
the context of collective cell migration where forces are shared at cell-cell junctions [125].
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3 Aims of the thesis
The central role of vinculin in cell adhesion, FA dynamics and intracellular force transduction
is broadly recognized. However, the role of its splice variant metavinculin remains obscure.
Therefore, this thesis analyzes the role of metavinculin with respect to cell adhesion and
intracellular force propagation. A better knowledge about mechanotransduction across
metavinculin also helps to understand how mechanical misregulations in diseases like
cardiomyopathy or atherosclerosis could evolve. The specific aims are:
Aim 1) Comparison of vinculin and metavinculin expressing cell lines
To distinguish the effects of vinculin and metavinculin on FA morphology and cell spreading,
fluorescently tagged constructs will be compared in a cell line depleted of both isoforms.
This model system is also suited to analyze differences in protein dynamics and interaction
partners.
Aim 2) Generation and characterization of FRET-based tension sensors (TSs) for vin-
culin and metavinculin
Genetically encoded FRET-based TS serve as a tool to measure the pN forces transduced via
a protein. Vinculin has already been identified as a mechanotransducer in FA and I plan to
generate a metavinculin TS to compare differences between both isoforms. To evaluate the
signal of FRET-TS in living cells, a measuring and data analysis routine for fluorescence
lifetime imaging microscopy (FLIM) has to be set up.
Aim 3) Comparative analysis of force transduction across vinculin and metavinculin
by insertion of mutations and changes in cellular environment
In the last step, I want to analyze point mutations which affect the F-actin interaction and the
HTIs of vinculin and metavinculin. Mechanical manipulation of the environment can for ex-
ample be achieved by uniaxial stretching of the substrate or change in substrate stiffness. To
measure whether metavinculin expression has an influence on active mechanotransduction,
traction force microscopy (TFM) will be implemented.
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4 Experimental Methods
4.1 Biochemical methods
4.1.1 Preparation of protein lysates for SDS-PAGE
Adherent cells were trypsinized, seeded out in a 6-well at 90% confluency and left to attach
in the incubator for 120min (37 ◦C, 5% CO2). After a fast washing step with phosphate
buffered saline (PBS) cells were lysed in 400 µl lysis buffer (Tab. 4.1) for 10min on ice. For
analysis of phosphorylated proteins a phosphatase inhibitor cocktail was added to the lysis
buffer.
Washing steps for detached cells involved 5min of centrifugation at 300 g, the lysis buffer
was directly added to the pellet. During the last 3min of the lysis cells were detached with
a cell scraper and centrifuged at 13.000 g for 10min at 4 ◦C. The supernatant was transfered
to a fresh tube.
Protein concentration was determined with a bicinchoninic acid (BCA) protein assay kit
(Novagen User Protocol TB 380 Rev. D0111 JN). The reaction was incubated for 30min at
37 ◦C and absorbance at 562 nm was measured with a plate reader (Tecan Sunrise microplate
reader, Mannedorf Switzerland). Intensity values were background corrected and fitted
with a custom written MATLAB program and adjusted to final concentrations of either
0.3mg/ml or 1mg/ml. After adding 4 x Laemmli buffer (Tab. 4.2) samples were denatured
for 5 min at 95 ◦C and either cooled to room temperature (RT) on ice for immediate loading
to a sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (SDS-PAGE) gel or
stored at −20 ◦C.
4.1.2 Co-Immunoprecipitation using magnetic beads
For co-immunoprecipitations a 10 cm culture dish densly covered with cells was lysed in
400 µl lysis buffer (Tab. 4.1). To avoid breakdown of protein complexes all steps were
performed fast on ice or in the cold room. After the centrifugation step the cell lysate was
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Lysis buffer
150mM NaCl
50mM Tris pH 7.6
1% Triton-X-100
1-2 tablets/10ml protease inhibitor cOmplete Ultra
1 tablet/10ml phosphatase inhibitor PhosSTOP
Table 4.1: Lysis buffer
Laemmli 4 x pH 6.8
250mM Tris-HCl pH 6.8
20% glycerol
4% SDS
0.02% bromphenol blue
4% β-mercaptoethanol
buffer containing β-mercaptoethanol was stored at −20 ◦C
Table 4.2: Laemmli buffer
incubated with 50 µl of Anti-HA-Tag or Anti-GFP-Tag Micro Beads (µMACS Epitope Tag
Protein Isolation Kit # 130-091-122 or #130-091-125, Miltenyi Biotec). Magnetic beads were
washed as described in the general protocol from Miltenyi Biotec using lysis buffer instead
of Wash Buffer 1.
4.1.3 One-dimensional SDS-PAGE and Western blotting
To separate proteins according to size, SDS-PAGE was applied. While pre-made gels
(BioRAD Laboratoires GmbH, MiniProtean TGX Precast Gels, 10% or 4− 15% gels 10
wells with 30 µl, Cat. No. 456-1083 or 456-1033) proved adequate for fast testing of protein
amounts, self-made PAA gels had a higher quality and were better suited to separate bands
of similar height and quantify expression levels. After washing and assembly of glass molds
ammonium persulfate (APS) and N,N,N’,N’-tetramethylethylenediamine (TEMED) were
added to the stacking gel (Tab. 4.4) and it was thoroughly mixed and carefully pipetted
between the glass plates. The gel was allowed to polymerize for at least 45min, covered
with a layer of isopropanol. After removing the isopropanol layer a separating gel (Tab.
4.5) was poured on top and a 10-well comb was inserted. Up to 30 µl of denatured protein
sample, corresponding to a total of 1− 5 µg of protein was loaded into the wells of the gel.
Suited markers were used (e.g. prestained SDS-PAGE protein marker 6.5− 200 kDa Liquid
mix from SERVA Electrophoresis, PageRuler PLUS Prestained Protein Ladder 10− 250 kDa
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Thermo Scientific). Self-made PAA gels were run in SDS-PAGE running buffer (Tab. 4.3)
at 120V until the end of the stacking gel and turned up to 160V; pre-made gels were run
according to manufacturers recommendations, but no higher than 200V to avoid excessive
heating.
SDS-PAGE running buffer 10 x
30.3 g Tris
144 g glycine
5ml 20% SDS
add to 1 l dH2O
Table 4.3: Running buffer
Stacking gel 5%
3.4ml ddH2O
630 µl 1.5M Tris-HCl pH 6.8
830 µl 30% PAA
40 µl 10% SDS
for polymerization
40 µl 10% APS
4 µl TEMED
Table 4.4: Stacking gel
Separating gel 10%
4.0ml ddH2O
2.5ml 1.5M Tris-HCl pH 6.8
3.3ml 30% PAA
100 µl 10% SDS
for polymerization
100 µl 10% APS
10 µl TEMED
Table 4.5: Separating gel
Next, proteins were transfered to a polyvinylidene difluoride (PVDF) membrane by western
blotting. Activation of the membrane was achieved by short soaking with methanol and
equilibration in 4 ◦C blotting buffer. For protein transfer, a sandwich consisting of three
foam sponges and a Whatman paper on each side was assembled and soaked in blotting
buffer (Tab. 4.6). Inside the sandwich the PAA gel was positioned on top of the PVDF
membrane, with the gel oriented towards the cathode and the membrane towards the anode.
29
4.1 Biochemical methods
A voltage of 100V for 1.5 h or 20V overnight (o/n) was applied to the transfer apparatus,
which was kept at 4 ◦C with a cool pack of ice and constant stirring.
SDS-PAGE blotting buffer 10 x
800ml 1 x SDS-PAGE running buffer w/o
SDS
200ml methanol
Table 4.6: Blotting buffer
The sandwich was disassembled and rinsed with Milli-Q filtered water (ddH2O) and TBS-T
4.7. For blocking of unspecific binding sites the membrane was covered with 5% skimmed
milk in tris buffered saline (TBS) polysorbate 20 (Tween20) (TBS-T) and left to shake at RT
for 45min. Primary antibodies were diluted according to Tab. 10.5. and incubated 1 h or
o/n in either 5% skimmed milk or 5% BSA. After washing three times 5min with TBS-T
the secondary antibodies were left to incubate for 1.5 h at RT, followed by a washing step.
Detection of chemiluminescence signal was enabled by soaking the membrane in a 1 : 1
mixture of luminol and peroxide (Immobilion Western, Millipore Corporation, Billerica USA,
Cat. No. WBKLS0500) for 5min in the dark. The signal was detected using an ImageQuant
LAS-4000 (Luminescent Image analyzer, GE Healthcare Bioscience) with typical exposure
times ranging from 8 s to 3min.
To enable parallel analysis of multiple different proteins, the membrane was either cut
into appropriate pieces prior to incubation with the first antibody or stripped after the
chemiluminescence analysis. For antibodies from different species, a mild stripping buffer
(Tab. 4.8) was used. The membrane was incubated twice for 10min in stripping buffer,
washed two times for 10min in PBS and two times for 5min in TBS-T. The membrane was
blocked and incubation with antibodies proceeded as described before.
TBS buffer 10 x pH 7.4
80 g NaCl
23.4 g Tris-HCl pH 7.4
approx. 16ml HCl
for TBS-T add 1 ml Tween 20 to 1 l TBS
Table 4.7: TBS buffer
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Mild stripping buffer
15 g glycine
1 g SDS
10ml Tween 20
add up to 1 l ddH2O and adjust to pH 2.2
Table 4.8: Mild stripping buffer
4.1.4 Purification of IpaA
The bacterial entry protein IpaA was purified for use in actin ultracentrifugation experiments
according to the protocol used by [57]. To start a bacterial culture, 1 µl of pGEX vector
plasmid with IpaA complementary deoxyribonucleotide acid (DNA) (cDNA) was transfected
into 50 µl competent BL-21 cells. A single clone was picked and a starter culture of 20ml was
grown o/n and 8ml of this culture were used to let 200ml bacteria in lysogeny broth (LB)
medium grow to an optical density (OD) of 1 at 600 nm. At this point 0.5mM IPTG were
added for induction and bacteria were kept on 37 ◦C for 3 h. Coomassie control staining
revealed a clear band corresponding to IpaA (70 kDa) with a GST-tag (26 kDa) at around
100 kDa (Fig. ?? C). Cells were pelleted and lysed in 3ml binding buffer by sonicating
at least three times for 30 s with 30 s rest on ice in the cold room (phenylmethylsulfonyl
fluoride (PMSF) is not stable and stocks of 10− 100mM in ispropanol were kept at 4− 8 ◦C).
After centrifugation at 10.000 g for 10min an insoluble pellet, containing the GST-tagged
IpaA formed at the bottom of the tube and was resuspended in binding buffer for washing.
Sonication and centrifugation were repeated twice until the final pellet was solubilized in
binding buffer containing 6M urea. Dialysis o/n at 4 ◦C against 1M urea in 5 l dialysis
buffer containing 10% glycerol was necessary for refolding of IpaA and followed by at least
2 h dialysis against storage buffer. Before usage, dialysis tubes (Membra-Cell MC18 Cat.
No. 300589260) were cut into pieces of 3 cm and boiled for 5min with 20 µl 0.5M EDTA in
2ml ddH2O. The solution was discarded and washed three times for 5min with ddH2O.
After repeating boiling and washing once more, dialysis tubes were boiled in ddH2O for
10min and stored at 4 ◦C. For the dialysis, the tubes were handled with sterile forceps and
assembled using 5ml dialysis capsules (Micro Dialysis Capsules QuixSep). Prior to usage,
storage buffer was exchanged to hypotonic F-buffer 4.12 using a PD-10 desalting column
(Amersham Biosciences Cat. No. 17-0851-01).
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Binding buffer
500mM NaCl
200mM Tris-HCl pH 7.9
0.1% Triton-X
5mM imidazole
2mM PMSF
1 x protease inhibitor cOmplete Ultra
Table 4.9: Binding buffer
Dialysis buffer
150mM NaCl
10mM Tris-HCl pH 7.5
10mM EDTA
1.0% β-mercaptoethanol
0.02% NaN3
10% glycerol
Table 4.10: Dialysis buffer
4.1.5 Production of hypotonic cell lysates
Two 10 cm culture dishes of confluent phoenix (human embryonic kidney 293 (HEK 293))
cells were transfected with 20 µg DNA (section 4.2.4) and grown for 3 days with daily change
of medium. As cells were super-confluent they could be detached by pipetting rigorously
with 10ml PBS, even without extra addition of EDTA. They were spun down at 1.000 g for
5min at 4 ◦C and resuspended in 2ml ice-cold hypotonic F-buffer. Cells were treated for at
least 3min with a glass homogenizer (Dounce) and centrifuged at 16.000 g for 10min in the
cold-room. The supernatant was aliquoted into 400 µl and stored at −80 ◦C for multiple
weeks.
4.1.6 Ultracentrifugation assay for F-actin binding
All steps involving protein lysates were done on ice or in the cold-room at 4 ◦C. Lysates with
and without IpaA were prepared according to Tab. 4.13 and Tab. 4.14. Actin from rabbit
muscle at a concentration of 1mg/ml in ddH2O (Sigma Cat. No. A 2522) was used. As a
control, 30 µl of each sample was denatured with 10 µl 4 x Laemmli buffer for 5min at 95 ◦C.
The rest of the mixture was kept on ice for 30min and centrifuged in a Beckmann TLA-45
centrifuge for 30min at 125.000 g. For each sample 45 µl of supernatant were denatured
with Laemmli buffer. All remaining supernatant was sucked off carefully using a pipett tip
32
4.1 Biochemical methods
Storage buffer
150mM NaCl
10mM Tris-HCl pH 7.5
0.1mM EGTA
0.1mM EDTA
1.0% β-mercaptoethanol
0.02% NaN3
15% glycerol
Table 4.11: Storage buffer
Hypotonic F-buffer
20mM Tris-HCl pH 7.5
2mM NaCl
0.2mM EGTA
0.5mM DTT
0.02% NaN3
2 x protease inhibitor cOmplete Ultra
Table 4.12: F-buffer
and the remaining pellet was resuspended in 50 µl 1 x Laemmli buffer. For each fraction
(total, supernatant and pellet) 20 µl were loaded on a PAA gel and analysed by western
blotting as desribed in section 4.1.3. Depending on protein concentration, the lysates had to
be diluted 1 : 5 or 1 : 10 to avoid over-exposure during western blot analysis.
Mixture containing no IpaA (total 400 µl)
20 µl KCl (1M)
20 µl ATP (10mM)
16 µl actin
200 µl hypotonic lysate
144 µl hypotonic F-buffer
Table 4.13: Lysate without IpaA
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Mixture containing IpaA (total 400 µl)
20 µl KCl (1M)
20 µl ATP (10mM)
16 µl actin
200 µl hypotonic lysate
44 µl hypotonic F-buffer
100 µl IpaA
Table 4.14: Lysate with IpaA
4.2 Cell culture methods
4.2.1 Handling of mouse embryonic fibroblast and telomerase
immortalized human myometrial cells
Standard cell culture conditions were achieved by an incubator permanently kept at 37 ◦C
and 5% CO2. For mouse embryonic fibroblasts (MEF), Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1 x streptomycin/penicillin
(s/p) (growth medium) was used; for human myometrial cells a mixture of 1 : 1 of DMEM
and Ham’s F12 nutrient mixture was used. Cells were regularly split using 1ml of trypsin
for a medium cell culture flask after washing with 10ml PBS. Approximately 5min were
enough for the cells to detach before resuspension in pre-warmed growth medium. To
store cells for a longer period of time, they were resuspended in cold freezing medium (Tab.
4.15), aliquoted to 1.5ml in cryo tubes and immediately transfered to a −80 ◦C freezer from
where they could be transfered to a liquid nitrogen tank after full freezing. Cells thawed
in a water bath at 37 ◦C and immediately transfered to pre-warmed growth medium. To
remove dimethylsulfoxide (DMSO), cells were pelleted by centrifugation of 300 g for 5min
and resuspend them in growth medium.
Freezing medium
70% growth medium
10% DMSO
30% FBS
Table 4.15: Freezing medium
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4.2.2 Generation of a clonal vinculin knockout cell line
Our lab received isolated fibroblastoid cells from genetically modified mice, in which the
vinculin gene were flanked by two loxP sites (named vinc f/ f ) (originally generated by Clare
Waterman and Ingo Thievessen). Immortalization of mouse embronyic fibroblasts (MEFs)
was achieved by adenoviral transduction of the SV40 large T-antigen. To generate clones,
cells were seeded at a low density in a 10 cm cell culture dish and grown until separated
clusters of multiple cells appeared. They were picked under a cell culture hood using
a light microscope and directly transfered to 96-wells with trypsin for 5− 10min. After
detachment, cells were transfered into a 24-well with 1.5ml growth medium and split into
small cell culture flasks. Clonal cell lines were analyzed by light microscopy and the cells
with fastest growth rate which showed large FA and cell size (clone No. 2) were used for
all further experiments (vinc f/ f ). To generate vinculin knockout cells the vinc f/ f cells
were transduced with Cre recombinase and sorted by fluorescence-activated cell sorting
(FACS). Single clones were picked as described before. The clone with the most similar
morphological features to the original vinc f/ f cell line was selected (clone No. 2-2) and is
hereafter called vinc−/−.
4.2.3 Transient transfection of cDNA constructs using Lipofectamine
To transfect fluorescent constructs into vinc−/− cells, the Lipofectamine 2000 Reagent was
used (invitrogen, Cat. No.11668-019). Target cells were seeded in a 6-well at 70− 90%
confluency and were allowed to adhere for at least 2 h before medium was changed to 2ml
growth medium without s/p. For each sample 250 µl Opti-MEM were mixed with 10 µl
Lipofectamine 2000 reagent. A second tube containing 250 µl Opti-MEM and 4 µg of the
desired cDNA was prepared. Both tubes were left to incubate in the cell culture hood for
5min before they were mixed and incubated for another 20min. The total mixture of 500 µl
was added dropwise to the cells. After 6 h the medium was changed to normal growth
medium containing antibiotics. Cells were analyzed within 24− 48 h after transfection.
4.2.4 Retroviral infection using the Phoenix cell system
For many applications, especially biochemical analysis, transiently transfected cells are
unsuitable and a stable expression is needed. Our system of choice was the Phoenix (HEK
293) cell line which has been described in [126]. Prior to infection two 10 cm cell culture
dishes of phoenix cells were seeded at 80% confluency for each construct in growth medium
which was exchanged to 7ml growth medium containing 3.5 µl 50mM of the lysosome
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inhibitor chloroquine before transfection. The plasmid DNA was precipitated using calcium
chloride (CaCl2) and mixed dropwise with HBS while vortexing according to Tab. 4.16.
After 8 h medium on the Phoenix cells was changed to 7ml fresh growth medium. On
the next day, the retroviral supernatant was collected and 8 µl of polybrene are added,
medium on Phoenix cells is exchanged to fresh growth medium. The supernatant was
sterile filtered and added to previously seeded target cells. Medium exchange and addition
of supernatant were repeated three more times at approximately 12 h. After the infection,
cells were sorted for high expression levels using FACS with a FACSAria cell sorter IIu (BD
Biosciences). Gates were chosen to ensure equal mean expression level for different cell
lines. Alternatively, infected cells can be challenged by puromycin treatment for 72 h at a
concentration of 2 µg/ml in growth medium.
Phoenix cell infection mixture
20 µg plasmid DNA
61 µl CaCl2
add to 500 µl ddH2O
add 500 µl 2 x HBS while vortexing
Table 4.16: Phoenix infection mix
HBS pH 7.0
280mM NaCl
50mM Hepes
1.5mM Na2HPO2 × 2 H2O
add up to final volume ddH2O
Table 4.17: HBS
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4.3.1 General remarks on cloning of cDNA constructs
Before cloning, a strategy for each construct was designed using the virtual cloning software
Lasergene (DNASTAR) and plasmid maps were used throughout the whole process to con-
trol for fragment sizes and to check sequencing results. Each cloning step involved digestion
of DNA by suited enzymes (New England Biolabs GmbH (NEB)) and dephosphorylation of
the vector followed by gel electrophoresis and extraction from agarose gel. The extracted
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DNA was ligated, transformed into competent Escherichia Coli (E. Coli) cells and single clones
were picked from bacterial plates and checked by control digestion and sequencing.
DNA fragments were either amplified by Polymerase Chain Reaction (PCR) as described
in section 4.3.2 or subcloned directly by enzymatic cutting of an existing DNA. As a vec-
tor either the pBlueskript (pBSK) vector or modified versions of the pLPCX vector where
used. Those modifications included alterations of the multiple cloning sites (pLPCXmod
cloning site 5’-BglII-ApaI-HindIII-EcoRI-BamHI-XhoI-NotI-3’), deletion of the NotI cutting
site (pLPCXmod ∆ N) or deletion of the cytomegalovirus (CMV) promoter (modified pLPCX
(pLPCXmod) ∆ CMV). Plasmid DNA from sources outside the lab also was contained in
pEX, pLL and pCAG vectors, but those where not used directly for cloning.
4.3.2 Protocol for normal, overlap extension and mutagenesis PCR
PCR is a standard method to modify DNA, e.g. by insertion of digestion sites, stop codons
or mutations. Controlled temperature gradients are used to denature DNA strands and
amplify pieces between so-called primers, which consist of short oligonucleotide strands
that bind specifially to the DNA strands. In general, the protocol for touchdown-PCR (Tab.
4.19) with a PCR mix (Tab.4.18) containing primers, dNTPs, template DNA and Pfu Ultra
polymerase was used.
PCR mix
5− 20 ng template DNA
5 µl 10 x reaction buffer
4 µl dNTP (2.5mM)
2 µl forward primer (5 pmol)
2 µl reverse primer (5 pmol)
1 µl Pfu Ultra polymerase
add to 50 µl ddH2O
Table 4.18: PCR mix
For tension sensor and control constructs, it was necessary to create an insertion, in the
middle of the cDNA by overlap extension PCR. Two products A and B were generated by
two independent PCRs and are purified on an agarose gel and used as input for a third PCR.
In addition to the standard forward (F) and reverse (R) primers forward (Fi) and reverse
(Ri) insertion primers coding for the insertion fragment and 25− 35 nucleotides down- or
upstream of the insertion site were generaetd. For PCR A primers F and and iR are used, for
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Touchdown PCR
Step time temperature
1 3min 95 ◦C initial denaturation
2 20 s 95 ◦C denaturation
3 20 s 68 ◦C primer annealing
4 15 s/kbp 72 ◦C elongation
5 20 s 95 ◦C denaturation
6 20 s 60 ◦C primer annealing
7 15 s/kbp 72 ◦C elongation
8 5min 72 ◦C final elongation
9 ∞ 4 ◦C store
Steps 2-4: repeat 8 times, always reduce annealing temperature by 1K
Steps 5-7: repeat 30 times
Table 4.19: Touchdown PCR
PCR B primers iF and R are used at standard concentrations. The final PCR C uses primers
F and R as well as both products A and B as templates according to Tab. 4.20.
product  C
5’
5’3’
3’
overlap  extension
PCR
R
F
3’
3’
5’
5’
B
product  A product  B
5’
3’ 5’
3’
5’
3’ 5’
3’
1.  PCR 2.  PCR
5’
5’3’
3’
iFF
RiR
A
Figure 4.1: Schematic view of overlap extension PCR To generate tension sensor constructs an overlap
extension PCR was used. Strands of cDNA are shown in gray and the resulting modified sequence is shown in
red. A. In the first step two different PCRs generate product A and B by using the indicated primers. B. The
overlap extension PCR fuses both products to the final outcome (C) which contains the modified sequence. In
case of tension sensor cloning this is the insert for the linker. Figure taken from [105].
To introduce or correct mutations, we used site directed mutagenesis according to instruc-
tions of the QuikChange II kit (Agilent Technologies, Cat. No. 200523). Primers were
designed according to manufacturers guidelines and 125 ng of each were added to the
PCR mix. A modified PCR program has to be used as circular and not linearized DNA is
amplified and compared to the touchdown PCR a longer elongation time but no temperature
reduction is needed (Tab. 4.22). The final PCR product was cooled for 2min on ice and 1 µl
of the restriction enzyme DpnI was added to each reaction tube, mixed, and incubated for
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PCR mix overlap
5− 20 ng template DNA
5 µl 10 x reaction buffer
4 µl dNTP (2.5mM)
2 µl forward primer (5 pmol)
2 µl reverse primer (5 pmol)
1 µl DNA template A (50 ng/µl)
1 µl DNA template B (50 ng/µl)
1 µl Pfu Ultra polymerase
add to 50 µl ddH2O
Table 4.20: Overlap PCR
1 h to digest the parental supercoiled and methylated double stranded DNA (dsDNA). For
transformation, 1 µl was added to 50 µl of cooled competent cells and left to incubate on ice
for 30min followed by 45 s heat-shock in a water bath at 42 ◦C and 2min on ice. 500 µl of
pre-heated LB were added to the transformation reaction and incubated at 37 ◦C ro 1 h with
constant shaking. The entire transformation reaction was split and 250 µl were plated on
ampicillin containing bacterial plates. The final plasmid had to be completely sequenced as
the PCR reaction could have introduced mutations in the insert as well as into the backbone.
For sequencing 15 µl of ddH2O containing 1 µg and 2 µl of primer (10 pmol) were sent to
MWG Biotech.
QuikChange mutagenesis PCR mix
5− 50 ng template DNA
5 µl 10 x reaction buffer
4 µl dNTP (2.5mM)
125 ng oligonucleotide primer 1
125 ng oligonucleotide primer 2
1 µl Pfu Ultra polymerase
add to 50 µl ddH2O
Table 4.21: QuikChange PCR mix
4.3.3 DNA digestion, gel electrophoresis, extraction, ligation and
transformation
Cutting sites for restriction enzymes were either present in the cDNA of our constructs or
could be inserted via normal or overlap extension PCR. Digestion mix contained cutting
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QuikChange mutagenesis PCR
Step time temperature
1 30 s 95 ◦C initial denaturation
2 30 s 95 ◦C denaturation
3 1min 68 ◦C primer annealing
4 1min/kbp 72 ◦C elongation
5 ∞ 4 ◦C store
Steps 2-4: repeat 12 times for point mutation, up to 18 times for multiple amino acid changes
Table 4.22: QuikChange PCR
enzymes and DNA in the appropriate buffer (Tab. 4.23). Incubation times and temperatures
were determined by the Double Digest Finder tool from New England Biolabs website
(https://www.neb.com/tools-and-resources/interactive-tools/double-digest-finder). For
some enzymes with very different properties like ApaI and NotI two sequential digests
lead to better results than one double digest. In case of only a single enzyme digest and
to enhance ligation efficiency the vector DNA was dephosphorylated by incubating it two
times 30min at 37 ◦ with 1 µl calf-intestinal-phosphatase (CIP).
Digestion mix
1− 2 µg DNA
3 µl 10 x reaction buffer (enzyme specific)
1.5 µl 20 x bovine serum albumin (BSA)
(2mg/ml)
1 µl enzyme A (10.000 units/ml)
1 µl enzyme B (10.000 units/ml)
add to 30 µl ddH2O
Table 4.23: Digestion mix
After digestion and desphosphorylation, DNA was immediately loaded onto an agarose
gel to separate DNA from enzymes and avoid unspecific effects. Electrophoresis gels were
prepared by dissolving 1% agarose in tris-acetic acid-EDTA (TAE) buffer (Tab. 4.24) and
boiling it in a microwave for 2min at 900W. The gel was cooled down to 50− 60 ◦C, 3,8-
diamino-5-ethyl-6-phenylphenanthridiniumbromid (ethidium bromide) was added and it
was poured into molds with a 10-well comb. DNA was mixed with 10x loading buffer
(Tab. 4.25) and 15 µl of 1 kb DNA standard (NEB, Cat. No. N3232) was used as reference.
Gels were run at 80− 120V for 20− 40min. DNA with intercalated ethidium bromide was
visualized on a Mini BenchTop UV Transilluminator (UVP, Cat. No. M-10E95-0180).
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10 x TAE buffer
242 g Tris
57.1ml acetic acid
100ml EDTA (0.5M, pH 8.0)
add to 1 l ddH2O
Table 4.24: TAE buffer
Loading buffer
52% glycerol
60mM EDTA
0.1% bromphenol blue
0.1% xylene cyanol
0.2% orange G
add to 50ml ddH2O
Table 4.25: Loading buffer
DNA bands of desired sizes were cut out with a razor blade and transfered to Eppendorf
tubes. For extraction of DNA from agarose gels, the mi-Gel Extraction Kit (metabion, Cat.
No. mi-GEL50), which is based on binding of DNA to silica-based membranes in chaotropic
salts, was used according to the standard protocol. Purified vector and insert were ligated at
a ratio of 1 : 3 for 1 h at RT (Tab. 4.26). Amount of vector and insert was estimated from
intensity of bands, normalized by DNA size.
Ligation mix
0.01− 0.03 ng vector DNA (e.g. 1 µl)
3 x molar excess insert DNA
1.5 µl T4 DNA ligase buffer
1 µl T4 DNA ligase
add to 15 µl ddH2O
Table 4.26: Ligation mix
DNA was transformed into competent bacteria, 6 µl of ligase mix were added to 60 µl of
freshly thawn competent XL-1 cells and incubated on ice for 20min. Bacteria were heat
shocked at 42 ◦C for 45 s followed by 2min on ice. 700 µl pre-warmed LB medium free of
antibiotics was added and the mixture was incubated at 37 ◦C for 1 h with gentle shaking
before plating 500 µl on bacterial plates (15 g of agar for 1 l of LBamp). After o/n incuba-
tion at 37◦C single colony clones were picked and transfered into 3ml LBamp medium in
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bacterial growth tubes and grown shaking at 37 ◦C until they reached the required optical
density after 8− 16 h.
Lysogeny broth (LB) medium
10 g NaCl
10 g tryptone-peptone
5 g yeast extract
add to 1 l ddH2O
Table 4.27: LB medium
Plasmid DNA was isolated from E. Coli cells to check for positive clones by control digest or
sequencing. To generate stocks of DNA for later use in transfection, 200ml LBamp were
grown o/n. To prepare small amounts of DNA, I used a mi-Plasmid Miniprep Kit (metabion
AG, Cat. No. mi-PMN50) while large amounts for later use in cell culture were generated
using a Midi/Maxiprep Kit (NucleoBond Xtra plasmid purification, Macherey-Nagel Cat.
No. 74010.50). Bacteria were be stored for longer times by adding 600 µl of 86% glycerol to
500 µl of fresh bacteria and freezing it to −80 ◦C.
4.3.4 Cloning of vinculin and metavinculin constructs
To generate fluorescently tagged constructs of vinculin and metavinculin, we used human
vinculin cDNA (Accession number BG284191, Clone ID: IRATp970G0639D) and changed
mutations (E142K, C636G and A901P) with a QuikChange Mutation Kit (section 4.3.2).
Insertion sites (5’ApaI/3’XbaI) were generated by PCR and vinculin cDNA (1-1066) was
cloned into a pBSK vector. To insert the metavinculin tail an oligonucleotide encoding
amino acids 874-1134 was synthesized (MWG Biotech) and cloned in using 5’AvrII/3’XbaI
sites. All C-terminal fluorophores (venusA206K, mCherry, enhanced blue fluorescent
protein (EBFP)) were amplified by PCR with (5’ XbaI/3’NotI) sites and cloned into pBSK-
vinculin or -metavinculin. The 5’ApaI/3’NotI sites were used to move the constructs into a
modified pLPCX (pLPCXmod) vector to generate the final constructs vinculin-venus (VV),
metavinculin-venus (MV), vinculin-mCherry (VC), metavinculin-mCherry (MC), vinculin-
EBFP (VB), metavinculin-EBFP (MB).
4.3.5 Cloning and insertion of tension sensor constructs
We choose the proline rich linker region in the middle of vinculin and metavinculin and
inserted tension sensors or internal fluorophores between aa 883 and aa 884. To this end we
42
4.4 Biophysical methods
generated a pBSK with a modified multiple cloning site (MCS) lacking NotI (5’-ApaI-XhoI-
SalI-ClaI-EcoRI-BamHI-XbaI-3’) and cloned in a linker containing a 5’SalI and a 3’NotI site
by overlap extension PCR using primers C30 and C31. The linker construct was transfered
into pLPCXmod and internal fluorophores and tension sensor peptides venus-flagelliform
peptide (F40)-mCherry and YPet-HP35-mCherry were inserted using ’5XhoI/NotI3’ sites
which lead to destruction of the SalI site. For activation sensor constructs the tail of vinculin
or metavinculin and a fluorophore was amplified by PCR and added to constructs with
internal fluorophores via 5’NotI/NotI3’. Cardiomyopathy related mutations Arg975Trp,
Ala934Val, the HTI mutations (N773A, E775A) and other point mutations were generated by
QuikChange Mutagenesis. To introduce mutations of multiple amino acids, as in the case of
metavinculin DDY945NTL, overlap extension PCR was applied.
4.4 Biophysical methods
4.4.1 Handling of micropatterns
During this project two different kinds of micropatterns were used: cross-shaped PEG-coated
micropatterns fabricated by Dr. Julien Polleux and commercially available triangular patterns
(CYTOOchips Y-M-FN, Cat. No. 10-011-10-18). Both were printed by photolitography onto
20 x 20mm boro-silicate glass. Custom made patterns had to be coated before use with
10 µg/ml FN o/n at 4 ◦C. Glass slides were mounted, facing with the micropattern upwards,
onto plastic microscopy dishes with a hole in the bottom of 15mm diameter, using a two-
component dentist glue (Picodent Twinsil, Cat. No. 200 2.1) mixed at a ratio of 1 : 1
immediately before use. The glue was only attached to the rim of glass slides and they
were left to dry for at least 20min at RT. Non-confluent cells were trypsinized and seeded
onto the dishes in DMEM supplemented with 10% FBS where they attached and started to
spread after approximately 30min. Adherence on custom made patterns was in general not
as specific as on commercial ones and we used DMEM supplemented with only 1% FBS to
prevent cells from extensive formation of ECM. After 6− 8 h cell started to migrate from
custom-made patterns wherease they remained seated on cytoo-micropatterns even after
o/n seating. However, it is advisable to image cells within 4− 6 h after seeding as they will
start to divide on the micropattern.
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4.4.2 Production of soft substrates for TFM
I prepared soft substrates of varying stiffnesses and embedded fluorescent microspheres
for use in TFM. They were either coated homogeneously with FN or micropatterns were
transfered onto the gel. The main steps involved in this process are activation of coverslips
surface, preparation of hydrophobic slides, preparation of PAA gels and activation of the
PAA surface or embedding of micropatterns. The protocol has been modified based on [111]
and a protocol from the MBL summer course 2007 by Gardel, Vesna and Jacobson.
To clean cover slips (#1.5, 25mm, Menzel, Cat. No. CB00250RA1), they were stirred with
soap in distilled water (dH2O) for 30 min, rinsed with dH2O and washed three times 30min
with dH2O. Finally, they were rinsed with EtOH and stored in 100% EtOH. Before use,
cover slips were flamed and placed into a teflon rack. The rack was put in a beaker with
2% 3-aminopropyltrimethoxysilane diluted in 200ml dH2O and stirred for 10min. For
activation of cover slips by amination, the racks were rinsed multiple times with dH2O and
incubated with 500ml dH2O for 10min. Racks were removed with a tweezer and remaining
water drops were blown away. Cover slips were dried at 37 ◦C for 30min and cooled down
to RT. Racks were immersed in 0.5% glutaraldehyde solution in 200ml PBS and stirred for
10min on a shaker. As before, cover slips were washed with three changes of dH2O and left
in a fresh beaker for 10min. Cover Slips were dried at RT, again with prior removal of big
water drops. It is advisable to prepare large amounts of slides at once (e.g. 20 - 40) as they
can be stored in a dust free environment for up to one week or in a dessicator for up to two
months.
Hydrophobic cover slips were prepared immediately before PAA polymerization. Cover
slips were flamed and placed in a teflon rack. To make them hydrophobic, single slides were
dipped in a beaker filled with 50ml of water repellent Rain-X solution (Rain-X, Cat. No.
80222200). Excess solution was removed with a Kimwipe, the cover slip was then immersed
in ddH2O and dried again with a fresh Kimwipe. In case of stains, the procedure was
repeated. Hydrophobic cover slips were distributed on an even surface for preparation of
PAA gels.
For PAA gels of different final Young’s modulus E the acrylamide to bis-acrylamide (bis-AA)
ratios were altered according to Tab. 4.28. Exact stock solutions for 8 kPa and 15 kPa PAA
gels are shown as examples in Tab. 4.29 and 4.30. Each time 445 µl of PAA stock solution
were degased in a vacuum chamber for 20min. I added 52 µl ddH2O containing fluorescent
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beads (e.g. 10 µl FluoSpheres Carboxylate-Modified Microspheres 0.2 µm or 3 µl FluoSpheres
Carboxylate-Modified Microspheres 0.04 µm, Cat. No. F8806 and F8789) to the PAA gel and
mixed it on a wheel.
For polymerization of PAA gels 0.5 µl TEMED and 2.5 µl fresh 10% APS were added to the
stock solution, mixed and 15 µl liquid PAA gel solution was pipetted immediately onto the
hydrophobic slides. Aminated cover slips were placed on top and left to polymerize in the
dark for 20min. Hydrophobic slides were detached carefully with a razor blade. All slides
with holes, damages or uneven PAA surface were discarded. Slides with PAA can be stored
up to several days in a 6-well with 3ml ddH2O on top in the dark at 4 ◦C.
In order to cross-link FN on PAA surfaces they need to be functionalized. I used ultraviolet
(UV) induced cross-linking of sulfo-SANPAH. A fresh vial of sulfo-SANPAH (Fisher Scien-
tific, Cat. No. 10474005) was equilibrated to RT to avoid moisture condensation and powder
was resuspend in 2ml DMSO. Aliquots of 2mg (80 µl) were shock-frozen in liquid nitrogen
and stored at −80 ◦C.
Due to the low stability of sulfo-SANPAH the next steps were performed at 4 ◦C. Excess
water was removed from PAA slides with a Kimwipe. One aliquot containing 2mg of
sulfo-SANPAH was diluted in 920 µl cold ddH2O and 200 µl were immediately pipetted
onto each slide. Gel surfaces were exposed to strong UV light for 5min at a distance of 8 cm
(Hanau Quarzlampe Typ 5261 Fluotest UV 210W). A brief washing step in a 500ml beaker
filled with ddH2O removed excess sulfo-SANPAH.
Drops of 50 µl of 1mg/ml FN solution were pipetted onto stretched parafilm and a cover slip
was placed on top to react o/n at 4 ◦C. Residual water was removed from the glass surface
which was mounted with the PAA gel facing upwards onto a microscope dish (35mm) with
a hole in the bottom (20mm) using two-component glue. A drop of PBS was placed on top
of the PAA gel to avoid drying. Next, dishes were filled with growth medium and cells
were seeded at 50% confluency for 4− 6 h. Immediately before acquisition medium was
changed to 1ml imaging medium.
To generate PAA gels with regularly shaped micropatterns we used either commercial
(CYTOOchips Y-M-FN, Cat. No. 10-011-10-18) or custom-made (courtesy of Dr. Julien
Polleux) glass slides coated with FN (section 4.4.1). To transfer the FN, micropatterned glass
slides were added on top of the PAA gel during polymerization, thus avoiding both the
amination and the cross-linking step.
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Young modulus and PAA ratios
E(kPa) PA % bisAA %
5.0 4 0.3
6.5 5 0.15
8.0 5 0.225
15.3 8 0.15
21.0 8 0.225
Table 4.28: PAA ratios
Stock solution for 8 kPa PAA gel
625 µl 40% acrylamide
562.5 µl 2% bis-acrylamide
3.262ml ddH2O
adding up to a total of 4.450ml
Table 4.29: PAA 8kPa
4.4.3 Fabrication of PDMS chambers for cell stretching
PDMS stretch chambers with 50 kPa stiffness were facbricated in collaboration with the
group of Prof. Rudolf Merkel from Forschungszentrum Jülich [110]. Chambers from PDMS
(Sylgard 184 Elastomere Kit, VWR Cat. No. 634165S) are produced by filling liquid basis
oil and cross-linking reagent into polystyrol molds and curing it in an oven. Handling of
unpolymerized PDMS is only possible with clean room gloves (Kimtech, G2993) as dirt
particles from conventional latex gloves interfere with the polymerization. Touching the
polished surface at the inner part of polystyrol molds with sharp objects will immediately
lead to scratches and they can only be cleaned with a Kimwipe soaked in isopropanol.
A mixture of 1 : 40 cross-linker and basis oil was weighed with a high-precision scale
using approximately 5 g of PDMS per chamber. Both ingredients were mixed thoroughly
with a plastic spatula for 5min and degased in a glas vacuum chamber for 20min. The
mixture was poured into cleaned molds and excess PDMS was removed. Cross-linking took
place in an bench-top incubator adjusted to 60± 0.1 ◦C for 16± 1h. Chambers were cooled
down for 30min before they were carefully removed from the mold and stored for up to
four weeks. Before use stretch-chambers were coated o/n with 550 µl of 10 µg/ml FN and
cells are seeded at 50% confluency in 1ml growth medium for 4− 6 h. Immediately before
acquisition medium was changed to 1ml imaging medium.
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Stock solution for 15 kPa PAA gel
1000 µl 40% acrylamide
450 µl 2% bis-acrylamide
3.00ml ddH2O
adding up to a total of 4.450ml
Table 4.30: PAA 15kPa
4.5 Microscopy methods
4.5.1 Characterization and spectra of used fluorophores
Our genetically encoded tension sensors use either the FRET-pair venusA206K/mCherry
or YPet/mCherry. The spectra of these fluorophores overlap (see Fig. 4.2) leading to
an efficient energy transfer and a theoretical Förster radius of about 5.8 nm. To enable
parallel observation of other expressed constructs, we utilized an EBFP-tag which allows
spectral separation of signal and thus does not interfere with FRET measurements. For
fluorescent beads and membrane dyes the far-red range of the spectrum above 600 nm was
the appropriate choice (CellMask Deep Red Plasma Membrane Stains, Invitrogen Cat. No.
C10046). Dyes from the Alexa series were best suited for immunostainings and were excited
and detected as shown in Tab. 4.31.
Fluorophore Excitation Emission
venus 512 nm 525− 565 nm
YPet 509 nm 525− 565 nm
mCherry 587 nm 600− 640 nm
EBFP 405 nm 475− 515 nm
Alexa568 568 nm 580− 620 nm
Alexa647 647 nm 660− 700 nm
Cell Mask Orange 554 nm 565− 595 nm
Cell Mask Deep Red 649 nm 660− 700 nm
Fluospheres Crimson 633 nm 645− 695 nm
Fluospheres Dark Red 660 nm 670− 700 nm
Table 4.31: Microscope settings for used fluorophores and dyes
4.5.2 Preparation of dishes and handling of cells for live cell microscopy
For live cell microscopy glass cover slips (#1.5, 25mm, Menzel, Cat. No. CB00250RA1) were
glued into holed (15mm - 20mm) plastic dishes using Picodent Twinsil at a ratio of 1 : 1
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and incubated with 10 µg/ml FN for 1 h at RT or o/n at 4 ◦. To allow cell adhesion but
not spreading, dishes were incubated for 2 h with 0.01% PLL and 1 h with 1% BSA. For
sterilization UV-light was applied for at least 20min.
4.5.3 Time-correlated single photon counting (TCSPC)-fluorescence
lifetime imaging microscopy (FLIM)
Fluorescence lifetimes was measured using a confocal microscope (Leica TCS SP5 X) running
the LAS AF Litesoftware equipped with a pulsed white light laser (WLL) (NKT Photonics)
with a repetition rate of 80MHz at 50% of full power. Single photons were detected
usingFLIM X16 78MHz TCSPC detector (LaVision Biotech, Germany) running the Imspector
software (Fig. 4.2 B). I used a bandpass filter 545/30 (AHF Analysentechnik, Germany) to
measure lifetimes of venus or YPet. Images were acquired at a scanning velocity of 400Hz, a
spatial resolution of 512 x 512 pixels and resulting image field coverage of 123.02 x 123.02 µm2
when using a 63 x water objective (HCX PL APO CS, NA = 1.2). This lead to a pixel dwell
time of 4.8 µs and a total time of 2.64 s per frame. The detection covered a time window
of 12.24 ns after the excitation pulse with a temporal resolution of 0.08 ns. In a typical
experiment, 20 frames were required to collect sufficient amount of photons from a single
cells. For each experimental condition 15− 20 cells were recorded and each experiment was
repeated at least 4− 5 times. On average only one out of several hundred laser pulses led to
a detected photon and shot noise statistics could be assumed for photon arrival times.
For each experiment, the lifetime of only the donor fluorophore venus was determined and
used for the calculation of FRET efficiencies. To visualize the instrument response function
(IRF), the lifetime of the fluorophore Rose Bengal (τ < 500 ps) was used [127].
4.5.4 Fluorescence recovery after photobleaching (FRAP) on
micropatterns
FRAP is a technique to determine turnover rates of molecules by recording recruitment
of unbleached molecules to a previously bleached region. Cells expressing fluorescently
tagged FA proteins were seeded for 4− 6 h on X- or Y-shaped micropatterns as described
in 4.4.1 where they formed regular and stable FAs at the corners. Images were acquired
on a Leica SP8 confocal laser scanning microscope equipped with a 63 x water objective
(HCX PL APO, NA=1.2) and a 37 ◦C heating chamber. The bleaching region was defined in
the LAS AF Lite Software to completely cover half of one corner while the other half was
used as a reference to exclude movement. Signal from all non-adjacent FAs was used to
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Figure 4.2: Set-up for TCSPC-FLIM measurements A. Example spectra for a FRET pair consisting of YFP
and mCherry. The emission spectrum of YFPs (yellow) like venus and YPet overlaps with the excitation
spectrum of mCherry (dashed red line). Therefore energy transfer occurs between both fluorophores and
they are a suited FRET pair. B. Schematic drawing of TCSPC-FLIM detection. The detection system for
TCSPC-FLIM consists of a rectangular 4 x 4 array of 16 PMT detectors which are connected to two parallel
8-channel time-to-digital converters (TDCs). These TDC are triggered by the pulsed laser and lead signals
further on to an field programmable gate array (FPGA) histogram counting module and via an USB-2 interface
to the computer. Figure taken from http://www.lavisionbiotec.com/flim-x16-tcspc-detector.html (September
2016)
correct for photobleaching. Two pre-bleach images were recorded at 2% of total laser power
at 514 nm for venus and 405 nm for EBFP fluorophore before bleaching the ROI with 100%
laser power for about 1 s. Fluorescence recovery was imaged during the next 300− 500 s
with 20 s intervals at 2% laser power. f
4.5.5 Imaging of substrates for TFM
Imaging of TFM slides took place at a Leica TCS SP 8 confocal laser scanning microscope
with a motorized x-y positioning stage and an incubation chamber at 37 ◦C. The system
was connected to a perfusion pump. For better imaging of thick substrates, I used a long
distance objective (HC PL APO 40 x/1.10 W CORR C S2, working distance 0.65mm). Data
precision was set to 12 bit and the spatial resolution was 60 nm per pixel. For excitation of
crimson fluorescent beads (FluoSpheres Carboxylate-Modified Microspheres, life technolo-
gies, Cat. No. F8806, diameter 200nm, 625/645 nm) we used the 633 nm laser line at 1%
of its maximum power and recorded the signal with a Leica hybrid detector (HyD) from
645− 695 nm (pinhole 1 AU).
Cells were handled and seeded as described in section 4.4.2. Control images for VV or MV
were taken with the 514 nm laser line at 5%, the surface of the PAA gel was determined
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in the transmission light channel. From the surface, the z-position was shifted 2 µm into
the gel and images of PAA gel were acquired at a scan rate of 50Hz. Beads need to have a
gaussian profile of at least 10 pixel width to be tracked by the automated algorithm. When
4− 5 brightfield, FA, and bead images were recorded, I added 1ml of killing buffer 4.32
via the perfusion pump. After complete cell lysis, the correct z-position was adjusted for a
second gel image; small shifts in x or y were corrected by the analysis program.
Killing buffer for TFM experiments
50mM Tris-HCl pH 7.6
150mM NaCl
1% Triton-X 100
1% SDS
Table 4.32: Killing buffer
4.5.6 Immunofluorescence staining
Cover slips for immunofluorescence were treated similar to dishes for live cell microscopy
(section 4.5.2), except that instead of gluing them to a plastic dish we placed glass slides of
10mm into 24-wells. For standard experiments cells were seeded at the required confluency
for 120min, quickly washed with PBS and fixed in 3.7% paraformaldehyde (PFA) for 10min
at RT. Fixation solution was sucked off and washed three times for 5min with PBS before
blocking with 2% BSA and 0.1% Triton-X 100 in PBS for 1 h at RT. In case of fluorescently
tagged protein in the sample all incubation steps were performed in the dark. The first
antibody was diluted in blocking solution (Tab. 4.33) according to Tab. 10.5 and incubated
for 1 h. After three washing steps with PBS (each 5min) the second antibody was diluted in
blocking solution and incubated for 1 h. To stain the actin cytoskeleton, we added phalloidin
during this step. The last washing step (three times 5min with PBS) was followed by
mounting in ProLong Gold antifading reagent (Life Technologies, Cat. No. P36934), which
were dried o/n at RT. Slides were imaged within a week and kept on 4 ◦ for long time
storage.
Immunostaining blocking solution
0.1% Triton-X 100
2% BSA in PBS
Table 4.33: Blocking solution
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5.1 Image analysis and feature extraction
5.1.1 Analysis of cell and focal adhesion (FA) size and shape
During this project I programmed versions v01-v04 of the FA analysis toolbox. This toolbox
is optimized for the fast and easy import and comparison of microscopy data from live
cell images and immunostainings. Images were imported into Matlab in the format .tif,
.lif, .lsm or as matrices and ROIs were manually set to exclude cytoplasmic background
and disturbing signal from adjacent cells. Next, data was blurred by a mean filter with a
3 x 3 pixel kernel. A three-level multi-Otsu thresholding algorithm was applied to the data
(http://www.biomecardio.com/matlab/otsu.html). The highest intensities were defined
as FA signal and converted into a binary image. After automatic filling of holes connected
components were defined on this binary image using the Matlab bwconncomp( ) function.
According to biological definitions only objects with a physical size larger than 1 µm2 are
included into the analysis and recognized as FA. Parameters were extracted according to
definitions of the Matlab regionprops( ) function and include total FA area per cell, size and
orientation of single FA, number of FA per cell, and FA eccentricity.
To determine cell size and eccentricity, we analyzed live cell images from cells treated with
a cell-permeable dye (CellMask Deep Red Plasma Membrane Stains, Invitrogen Cat. No.
C10046) or immunostainings of the F-actin cytoskeleton with phalloidin (Alexa Fluor 647
Phalloidin, Life Technologies Cat. No. A22287). When only data from FA stainings was
available, as in the case of TFM data, cell size was determined manually using ImageJ.
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A B
original filtered
Otsu  threshold FA  isolation
Figure 5.1: Extraction of cell size and eccentricity A. Even small features of cell circumference can be extracted
from actin immunostainings. B. Steps of the FA extraction algorithm: original data is filtered with a mean
filter of kernel 3 x 3 and subjected to a three-level Otsu threshold. After conversion into a binary image the FA
isolation takes place. Different colors mark individual FA. For each of them parameters like are, eccentricity
and orientation are defined.
5.2 Evaluation of TCSPC-FLIM data
5.2.1 Set-up of import routines and data structure
After recording, time-correlated single photon counting (TCSPC)-fluorescence lifetime imag-
ing microscopy (FLIM) data can be analyzed by the Imspector software, however, the
limitations of this program are very obvious as calculation of lifetimes requires multiple
steps, has to be done individually for each cell, and does not allow for further options like
feature extraction. Therefore I developed a user-friendly platform for data analysis which
could be managed without detailed knowledge about programing and allowed for flexible
handling of large data amounts in the range of terabyte (TB). Data can be loaded into the
program either via a graphical user interface (GUI) or by directly declaring a variable with
the paths leading to the data. A standard FLIM experiment, as described in section 4.5.3,
contains 20 cells with 15-20 measurement repeats for each cell. The default setting for
temporal resolution was 0.08 ns leading to 153 frames per image. Data was stored in the
.tif file format and could be accessed via the MATLAB imread( ) function. In a first step,
all frames are loaded in and repeats for one cell are merged. The total number of photons
for each time step is counted and photons from all time points and repeats are added up.
This gives a histogram of the number of photons in each time bin. The loading procedure is
robust, but very time consuming and could be optimized by using sparse matrix notation.
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5.2.2 Fitting of lifetime curves and definition of FRET efficiency
Prior to fitting, all histograms were aligned by determining the curve maximum for the
whole experiment and shifting single traces accordingly. The IRF was measured using Rose
Bengal dye, which has a very short lifetime (τ < 500 ps, Fig. 5.2 B) [127]). I also determined
the influence of excluded timepoints counted from the minimum of the histogram on the
lifetime fit (Fig. 5.2 A). Lifetimes were determined from the photon count histograms by
tail-fit using the Matlab fit( ) function with the non-linear least square method with equal
weight for all data points. The equation reads
f (t) = a e−t/τ + b (5.1)
with amplitude a, lifetime τ and background b. To evaluate the goodness of fit, we
calculated the coefficient of determination R2 and excluded data with R2 < 0.98. Fitting of
bi-exponential decays was implemented, but introduced additional degrees of freedom and
complicated the interpretation of data. To describe relative differences in FRET fitting of a
monoexponential decay is sufficient as there should be a monotonic relation between energy
transfer and lifetime. The absolute FRET efficiency E is defined as
E = 1− τDA
τD
(5.2)
with donor lifetime τD and lifetime of donor in presence of the acceptor τDA. The func-
tion expMERGE( ) can be used to compare and combine FRET efficiencies from various
experiments, constructs and analysis steps described in 5.2.3.
5.2.3 Analysis of FLIM data
For interpretation of biological data the separation of fluorescent signal from different spatial
regions is important. In the first step of data import a fluorescence image is generated from
all photons which arrived during the measurement, independent of their arrival time. This
image was used as an input for our thresholding routines and features were extracted.
The resulting binary mask from the FA analysis program was multiplied with the imported
FLIM image and all further calculations of lifetime used photons from this area. In general,
we restricted our data analysis to photon counts from FAs which were defined according
to section 5.1.1. The user could further restrict the analysis to FA of a special size, shape
or intensity value. For projects from other group members and collarboration partners I
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Figure 5.2: Cut-off value for monoexponential tail fit A. Dependence of fitted lifetime on number of time
points from the minimum of the photon count histogram for a typical venus control measurement. B. Signal
from Rose Bengal dye representing the IRF (logarithmic scale). After the first peak, the signal strongly decays
and oscillations occur at around 40 and 90 time bins (logarithmic scale).
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Figure 5.3: Fitting of lifetime A. Example raw data from venus lysates of different concentrations. B.
Histogram traces (blue) are shifted (red) to the maximum of the mean of all traces. For the tail fit only
signal 5 bins away from the maximum until bin 135 are taken, as indicated by the dashed gray bars. C.
Monoexponential fit of curve with highest and lowest photon count. One advantage of the TCSPC-FLIM
method is its independence from signal intensity.
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adjusted for the analysis to biological structures like kinetochores, hemidesmosomes, or
signal from Drosophila larvae.
To produce images of spatial distribution of lifetimes they were determined by a non-fitting
based approach through calculation of the mean photon arrival time. For this analysis
photons from 4 x 4 pixel regions were combined.
5.2.4 Statistical testing and considerations of measurement errors
Data for TS measurements is presented as boxplots indicating the 25% and 75% percentile.
The median is visualized by a red bar and whiskers reach to 2.7 times the standard deviation
σ. In the text, mean FRET values ± the variance are given. Bar plots show the mean value
and indicate variance by a red whisker. In some cases which are explicitely stated, the SEM
is shown instead of the variance.
The following tests were implemented to test statistical significance, the null-hypothesis are:
Kolmogorow-Smirnov-Test [kstest2( )]: both data vectors are from the same continuous
distribution.
Two-sample t-test [ttest2( )]: both data vectors are from a normal distribution with same
mean but can have different variances.
For all tests a significance level of α = 0.05 was used. I decided to use the Kolmogorow-
Smirnov test as a default because it does not require normality of the distribution. In my
opinion, the t-test is not an appropriate choice, because the variance needs to be taken into
account when comparing FRET data from TS constructs. Data for the same construct from
at least 3 − 4 independent repeats was pooled. The lifetime of a protein tagged with only
the venus fluorophore served as a control that donor lifetime does not change between
measurement days.
Independent of the measurement precision, photon count statistics are limited by shot
noise. A simulation of theoretical expected data precision was done by generating random
numbers from a Poisson distribution with a mean value defined by a monoexponential
decay with lifetimes and amplitudes comparable to experimental values. The detection
range is limited to 12.4 ns and measurement precision is higher for shorter lifetimes. Indeed,
the theoretical variance could already explain half of the variance for VV and vinculin head
tension sensor (VHTS). As we expected, variations of TS constructs were significantly higher
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than the shot noise, indicating that this sensor responds to biological factors and experiences
varying forces across cells (Fig. 5.4 B,C).
5.3 Analysis of biophysical data
5.3.1 Fitting of FRAP curves
Fluorescence intensity data and regions of interest (ROI) were imported into ImageJ as
.lsm or .lif files. The MacBiophotonics ImageJ plugin FRAP profiler performed automated
analysis of the data and generated raw and normalized recovery curves. Data was imported
into Matlab for further analysis. All traces that did not show bleaching to less than 20% of
the initial fluorescence intensity were removed from the analysis, as well as movies showing
a drift in the focus plane or movement of cells. Using the FA analysis algorithm, I tested
that mean initial intensity levels of cells were not significantly different. Next, mean and
variance of the normalized data was calculated and plotted against time after bleaching. I
assumed a reaction-dominated model [64, 128] for the recovery and fitted the equation
f (t) = A (1− e−ko f f ·t) (5.3)
with rate constant ko f f and mobile fraction A. The rate constant is connected to the half-life
τ1/2 which we used to characterize the FRAP recovery curves by τ1/2 = ln(2)/ko f f .
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Figure 5.4: Analysis of variance in experimental data A. Averaged standard deviation for 50 simulated
measurements. The variance shows a linear correlation with intensity and saturates at values of around 6.000
photons per measurement. B. Experimental data of fluorescence lifetimes for TS constructs and VV. Two
experiments from consecutive days are shown next to each other, each dot corresponds to measurement from a
single cell. C. Simulated data which takes shot noise into account, shows the theoretical limit of measurement
precision.
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5.3.2 Particle image velocimetry (PIV) and Fourier transform traction
cytometry (FTTC)
Here, I will describe analysis of an experimental method, which determines the displacement
field u(x) by tracking the position of fluorescent beads in compliant PAA gels before and
after removal of cells using a particle image velocimetry (PIV) plugin for ImageJ. Bead images
recorded before and after removal of cells were aligned using a template matching tool
which calculates the normalized 2D cross-correlation coefficient (Fig. 5.5 A.- C.). Knowledge
of the experimentally determined displacement field u = x￿ − x and the Green’s function
G(x, x￿) = G(x− x￿) leads to an equation for traction forces t(x).
u(x) =
￿
G(x, x￿)t(x￿)dx￿ (5.4)
This convolution integral can be inverted in Fourier space where it reads [108]
t˜(k) = G(k)−1u˜(k) (5.5)
pre post merge PIV FTTC
A DB C E
Figure 5.5: Traction force microscopy (TFM) analysis by FTTC A. Image of beads embedded in an elastic
PAA gel. A cell is seeded on top of the Y-shaped micropattern leading to deformations of the gel. B. Bead
image after releasing the cell-generated stress by addition of killing buffer. C. Aligned bead images (pre: red,
post: green), showing areas of large overlap (yellow) and shifted beads. D. Displacement field u(x) determined
from experimental data by PIV. E. Vector representation of the traction force field t(x) calculated by FTTC.
Scale bar: 20 µm
.
To solve equation 5.5, an algorithm from Benedikt Sabass [112] called Fourier transform trac-
tion cytometry (FTTC) was used. The experimental displacement field u(x) was smoothed
and interpolated to a regular grid using a frequency cut-off rule. Next, a Fast Fourier
transform (FFT) was applied and u˜(k) could be directly multiplied with the inverse Green’s
function G(k)−1. Determination of the Green’s function is possible for the geometrical
constraints of problem and more details are given in [112]. The resulting force field t˜(k)
was back-transformed into real space.
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The total strain energy per cell in pJ was now calculated from the single displacement
vectors as [129]
U =
l2
2 ∑n1,n2
∑
i=1,2
ti(n1, n2)ui(n1, n2). (5.6)
I used the traction force reconstruction tool programmed by Benedikt Sabass [112] to calcu-
late strain energies and traction forces from image data. For the analysis an interrogation
window size of 128 pixels for PIV and a smoothing parameter, which determines the
frequency cut-off for the FTTC, of lsmooth = 10−6 were choosen.
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6.1 Establishment and characterization of vinculin and
metavinculin expressing cell lines (vinc −/−)
6.1.1 Stable expression of vinculin and metavinculin in vinculin
knockout fibroblasts
The vinculin gene was deleted from vinc f/ f cells as described in section 4.2.2 and I used
retroviral infection to generate cells stably expressing vinculin-venus (VV) and metavinculin-
venus (MV) constructs (sec. 4.2.4, Fig. 6.1 D). All cell lines adhered to fibronectin (FN)
or collagen coated surfaces, however, vinc−/− proliferation rate was decreased. Western
blotting confirmed the lack of vinculin in vinc−/− cells and re-expression of VV and MV
similar to wildtype levels. Other core focal adhesion (FA) proteins like integrin-linked
kinase (ILK), paxillin, talin or focal adhesion kinase (FAK) did not show alterations in
their expression level (Fig. 6.3 A). The vinc−/− clone used for this study (clone #2-1,
Fig. 6.1 B) does not show reduced size and FA morphology. However, it is important to
note that other clones (e.g. clone #2-5, Fig. 6.1 C) with reduced size and even stronger
proliferation defects were discarded as they might have accumulated additional mutations
during immortalization and gene excision.
6.1.2 Metavinculin localizes to FA and rescues spreading defect caused
by vinculin deletion
I analyzed protein localization by live cell imaging and immunostaining and found localiza-
tion of VV as well as MV to FA, nascent adhesions and dorsal ruffles (Fig. 6.2 A). Size and
shape of FAs were not significantly different between both cell lines, however, expression
of vinculin-head-venus (VHV) lead to increased FA size (Fig. 6.2 B & Fig. 6.16 A-C).
Paxillin staining confirmed the presence of FA in vinc−/− cells (Fig. 6.3 B). Analysis of cell
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Figure 6.1: Generation of clonal vinc f/ f and vinc−/− cell-lines A. Immortalized clonal cell line with a
floxed vinculin gene (vinc f/ f ). B. Clone from knockout cell line #2-1 which has been generated from vinc f/ f
after addition of Cre and fluorescence-activated cell sorting (FACS). This cell line was used for all following
experiments as it does not show impairments in cell or FA size. C. Clone #2-5 shows severe growth defects
after deletion of vinculin by Cre. Some cells are polynucleated and FA size as well as proliferation is decreased.
D. Schematic illustration of cell line generation. Cells are immortalized by SV40-T, treated with Cre and sorted.
Constructs with a fluorescent tag are then introduced by stable or transient transfection. A.-C. All cells were
seeded on 10 µg/ml FN for 120min and stained against F-actin (red) and paxillin (green), scale bar: 20 µm
morphology at different time points showed a delayed spreading of vinc−/− cells, which
is most prominent after 120min and can be rescued by both VV and MV expression (Fig.
6.3 C). After several weeks in cell culture, the spreading defect of vinc−/− decreased signif-
icantly. All measurements performed for this thesis use cells from early passages. These
observations demonstrate that metavinculin can localize to FA in the absence of vinculin
and can compensate the lack of vinculin with regard to cell spreading and adhesion.
To determine whether vinculin and metavinculin localization depends on actomyosin
contractility, I treated cells with blebbistatin and Rho-associated protein kinase (ROCK)
inhibitor Y-27632, which both lead to reduced FA size and VV or MV intensity (Fig. 6.4).
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Figure 6.2: Localization of VV and MV constructs A. Immunostaining shows that both VV and MV localize
to FAs, dorsal ruffles and nascent adhesions. F-actin: green, venus-tagged constructs: red, scale bars: 20 µm,
cells seeded for 120min on 10 µg/ml FN. B. Detailed analysis of FA size in vinculin knockout (vinc−/−) cells
and rescue with VV and MV after 120min on 10 µg/ml FN. Histogram shows distribution of FA sizes in µm2.
No difference between mean FA size of VV and MV is observed (2.595± 0.0006 µm2 vs. 2.634± 0.0006 µm2 )
and sizes were slightly smaller compared to vinc−/− which showed a higher amount of large FA > 5 µm2
(2.805± 0.0006 µm2). Error is shown as SEM.
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Figure 6.3: Rescue of spreading defect by VV and MV constructs A. Western blot of vinc f/ f , vinc−/− cells
and rescues with VV and MV against typical FA proteins. A monoclonal green fluorescent protein (GFP)
antibody shows expression of fluorescent constructs and antibody against total vinculin confers expression
levels similar to wildtype. No differences in the expression of talin, FAK, paxillin and actin are observed.
B. Representative immunostainings after 120 min on 10 µg/ml FN show rescue of the spreading defect
in vinc−/−. F-actin (upper row) and paxillin (lower row) signal, scale bar: 20 µm. C. Quantification of
cellular eccentricity (vinc f/ f : 0.69± 0.24, vinc−/−: 0.39± 0.26, VV: 0.71± 0.26, MV: 0.68± 0.27) from three
independent experiments with at least 20 cells per cell line.
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Figure 6.4: Treatment of cells with blebbistatin and ROCK inhibitor A. VV and D. MV control without
blebbistatin. B. VV and E. MV treated with 30 µM blebbistatin for 10min. C. VV and F. MV cells treated with
Y-27632 10 µM for 10min. Cells were seeded for 120min on 10 µg/ml FN, scale bar: 20 µm
62
6.1 Establishment and characterization of vinculin and metavinculin expressing cell lines (vinc−/−)
6.1.3 Fluorescence recovery after photobleaching (FRAP) reveals
increased stability of metavinculin in FA
Protein turnover rates can be accessed by fluorescence recovery after photobleaching (FRAP)
(see section 4.5.4). Vinculin turnover depends on FA size and subcellular position [130]. I
seeded cells on X- or Y-shaped micropatterns to exclude these effects and ensure regular
FAs with comparable sizes that do not change during the measurement (see section 4.4.1,
Fig. 6.6 C). Bleaching of areas in the cytoplasm verified that the timescale of diffusion was
much faster than for protein incorporated in FA and we controlled for comparable FA size
and fluorescence intensities (Fig. 6.6 C).
VV
A B
MV
Figure 6.5: Immunostainings of cells on X-shaped micropatterns A. Vinculin knockout cells expressing VV
B. or MV. Both cell lines were seeded on X-shaped FN-coated micropatterns of 40 µm side length fabricated by
Julien Polleux. The F-actin cytoskeleton is shown in red, FAs are indicated by signal of venus tag (blue).
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Figure 6.6: FRAP experiments on X-shaped micropatterns A. Fit of recovery curves for VV (red), MV (black),
VV in presence of vinculin-mCherry (VC) (orange), MV in presence of metavinculin-mCherry (MC) (gray).
B. Recovery rates τ1
2
show faster turnover of VV compared to MV and no changes for paxillin turnover. C.
Comparison of pre-bleach intensity from live cell images of FA show no significant differences between VV
and MV.
Measurement of VV and MV expressing cells on X-shaped micropatterns revealed a slower
turnover rate (95.1 ± 3.87 s vs. 116.7 ± 3.75 s) and decreased mobile fraction (73 ± 1.6% vs.
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60 ± 1.7%) for metavinculin as compared to vinculin (Fig. 6.6 B). Co-expression of the same
amount of vinculin or metavinculin protein with mCherry tag (VC and MC) resulted in
faster turnover and even more pronounced difference between VV-VC and MV-MC cell
lines (57.75± 2.55 s vs. 88.67± 5.22 s) (Fig. 6.6 A & B). Next, I measured VV in the presence
of MC (and MV in the presence of VC), which resulted in turnover similar to VV-VC and
MV-MC (VV-MC: 69.73 ± 5.58 s and MV-VC: 97.79 ± 4.89 s) (Fig. 6.6 A & B).
To confirm these observation, I repeated experiments with VV and MV expressing cell lines
on commercial Y-shaped micropatterns (Cytoo) using a microscope with more sensitive
detection and better temperature control, which enabled us to increase measurement time
to 500 s. Again, metavinculin turnover was characterized by reduced turnover rates and
the mobile fraction was significantly decreased (VV: 75.58± 4.33 s and 73.5± 1.3%, MV:
100.8± 8.26 s and 58.16± 1.25%) (Fig. 6.7 B ). Increasing the degree of freedom by fitting a
stretched exponential f (x) = A · (1− exp(−(t/τ)β) lead to a higher variance of both mobile
fraction and lifetime. Assumption of two lifetimes f (x) = A1 · exp(−t/τ1) + A2 · exp(−t/τ2)
did not yield consistent results and only moderately influenced fit quality compared to
fitting one effective lifetime.
To test the effect on other FA proteins, turnover of overexpressed paxillin-mCherry and
talin-1-EBFP was measured in presence of VV or MV. No significant alterations in the
respective lifetimes or mobile fractions were observed (paxillin VV: 57.1 ± 4.7 s or MV:
58.5 ± 3.12 s (Fig. 6.6) and talin-1 VV: 102.1 ± 4.7 s or MV: 94.97 ± 11.13 s, p = 0.68 (Fig.
6.7)). Together, the data indicate that metavinculin has significantly reduced turnover rates
in FAs.
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Figure 6.7: FRAP experiments on Y-shaped micropatterns A. Recovery curves for VV (red) and MV (black)
show higher mobile fraction and faster turnover for vinculin. B. Turnover and mobile fractions for talin1-HA-
EBFP do not depend on co-expression of VV (blue) or MV (green). C. Control experiments for tension sensor
(TS) constructs reveal slower turnover for metavinculin tension sensor (MTS) (black) than for vinculin tension
sensor (VTS) (red) and decreased mobile fraction of MTS.
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6.2 Analysis of metavinculin interaction partners
6.2.1 Mass-spectrometry identifies changes in interaction with talin
To explain the decreased turnover rates of metavinculin in FA, I searched for changes in
binding or interaction partners which could explain the enhanced stability of metavinculin. A
first screen of the interactome was performed in cooperation with the group of Prof. Matthias
Mann from Max Planck Institute (MPI) of Biochemistry, Martinsried, using quantitative co-
immunoprecipiation mass spectrometry. Tagged constructs were pulled down using a GFP
antibody which also recognizes the yellow fluorescent protein (YFP) venus. Untransfected
vinc−/− cells served as negative control. Interestingly, an increased interaction (about
5-fold) of talin-1 with metavinculin was observed (Fig. 6.8 B). Other proteins enriched in
the metavinculin sample were structural maintenance of chromosomes 1A (SMC-1A) and
protein LLP homolog (Llph) (Fig. 6.8 C), which were not further analyzed because they
have been not described to localize to FAs.
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Figure 6.8: Analysis of (meta)vinculin binding partners by mass spectrometry A. Silver staining from a pull-
down experiment of VV and MV using α-GFP beads. B. Volcano plot of results from co-IP mass spectrometry
showing a 5-fold increase of interaction between MV and talin-1. C. Cluster analysis of the most significantly
enhanced proteins pulled down with VV or MV. A negative control was provided by analysis of vinc−/− cells.
n = 4 independent repeats for each cell line.
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6.2.2 Co-immunoprecipiation confirms increased affinity of metavinculin
for talin
To confirm results from mass spectrometry, I performed a manual pull-down of VV and MV
transfected cell lysates using magnetic beads and stained immunoblots with an antibody
against talin (details in 4.1.2). Binding of talin to vinculin was enhanced in accordance
with the 5-fold increase we observed in mass spectrometry results (Fig. 6.9 A). To confirm
the specificity of the interaction, I stably transfected talin-HA-EBFP and performed co-
immunoprecipitation by pulling on the HA-tag and evaluation with an α-vinculin antibody
recognizing both isoforms. Again, a higher amount of metavinculin interacted with talin
(Fig. 6.9 B).
The talin binding site is located within the vinculin and metavinculin head domain, which
is identical for both isoform. Increased interaction of metavinculin with talin therefore can
not be explained by a change in affinity between both binding partners, but needs to involve
other factors like changed head-tail interaction (HTI) for metavinculin, stabilization by other
FA proteins or interaction with F-actin.
A B
VV MV
GFP
talin-­1
GFP-­IP
VV MV
HA-­IP
vinc
talin-­1
Figure 6.9: Immunoprecipitation data indicating increased interaction of MV with talin A. Manual pull-
down experiments of VV and MV using magnetic beads coated with α-GFP and B. of talin-1-HA-enhanced
blue fluorescent protein (EBFP) using α-HA beads. Antibodies against vinculin, talin-1 and GFP were used as
indicated. A higher amount of talin is co-immunoprecipitated with talin-1 and vice versa.
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6.2.3 Actin binding upon activation by Shigella invasin (IpaA) is similar
for vinculin and metavinculin
Ultracentrifugation pull-down assays can be used to study whether proteins are co-pelleted
with F-actin. Full-length vinculin needs to be activated, e.g. by the bacterial invasin protein
IpaA, before it can bind to F-actin. I purified IpaA and added it to hypotonic cell lysates
of VV and MV cells together with polymerized actin as described in section 4.1.4 and 4.1.5
(Fig. 6.10 B). After the centrifugation step supernatant (S) and pellet (P) were stained with
α-vinculin antibody and compared with the amount of vinculin in the total control (T).
Only after addition of IpaA, vinculin and metavinculin could be observed in the pellet,
however, there was no difference in the respective amount being pulled down, indicating
similar binding affinity to F-actin (Fig. 6.10 D). This result is in accordance with experiments
using only the vinculin tail domain (Vt) or metavinculin tail domain (MVt) domain [54].
However, I know from previous work that binding affinity is not enough to characterize the
interaction of proteins with the F-actin cytoskeleton (see section 1.3.3).
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Figure 6.10: Probing of interaction of VV and MV with F-actin A. Coomassie staining showing expression
of IpaA with a GST-tag after induction with isopropyl-β-D-thiogalactopyranosid (IPTG). B. Actin ultra-
centrifugation assay of VV and MV in the presence of absence of IpaA. Only after addition of the bacterial
entry protein both VV and MV can be seen in the pelleted fraction (P) which indicates binding to F-actin. T:
total lysate, S: supernatant, P: pellet
Next, I wanted to confirm that vinculin and metavinculin indeed undergo a conformational
change upon binding to IpaA. A biosensor measuring vinculin activation has first been
introduced by [57] for both in vitro and live cell measurement and was adapted for use in
metavinculin (for cloning strategy please refer to 4.3.5). I analysed the lifetime of hypotonic
lysates (sec. 4.1.5) from cells stably transfected with vinculin activation sensor (VAS) or
metavinculin activation sensor (MAS) before and after addition of IpaA (sec. 4.1.4) and in
presence of F-actin. Sample preparation was identical to ultracentrifugation assays (Tab. 4.13
& 4.14). The expected decrease in Förster resonance energy transfer (FRET) efficiency (VAS
22.89± 0.22% to 8.89± 1.29% , MAS 11.98± 0.43% to 7.1± 0.12%) was observed and, as
67
6.2 Analysis of metavinculin interaction partners
anticipated, MAS showed a lower initial FRET as the fluorophores are separated by a longer
tail domain (Fig. 6.11 A).
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Figure 6.11: In vitro measurement of vinculin and metavinculin activation sensors (ASs) A. The FRET effi-
ciency of hypotonic lysates mixed with actin was measured before and after addition of IpaA. Conformational
changes are reported by a decreased FRET efficiency for both vinculin activation sensor (VAS) and metavinculin
activation sensor (MAS) after addition of IpaA. B. Vinculin activation sensor (AS) consists of an internal
mCherry fluorophore which was inserted between amino acids (aa) 883-884 of the unstructured linker region,
a venus tag is positioned at the N-terminus. In the closed or autoinhibited conformation fluorophores are
closer together, leading to higher FRET than in the open or active conformation. C. Fluorophore position for
metavinculin is identical, however, the distances between the fluorophores are altered due to the 68 aa long
insert.
6.2.4 Summary of biological characterization of cell lines
In the last section we learned that metavinculin can localize to FA even in the absence
of vinculin and rescues the spreading defect caused by vinculin deletion. Interestingly,
metavinculin exhibits higher stability in FA and its interaction with talin-1 is increased as
compared to vinculin. However, standard methods from cell biology and biochemistry have
limited insights with respect to the molecular function of metavinculin.
It has been shown that vinculin is a mechanotransducer and can bear piconewton (10−12N)
(pN) forces at sites of FA [10], but whether and how metavinculin transduces force remains
unclear. Thus, I decided to use FRET based biosensor constructs to compare forces across
both proteins in living cells.
68
6.3 Establishment and characterization of FRET-based biosensor constructs in living cells
6.3 Establishment and characterization of FRET-based
biosensor constructs in living cells
Here, I introduce time-correlated single photon counting (TCSPC)-fluorescence lifetime
imaging microscopy (FLIM) as a robust method to access the fluorescence lifetime of FRET
constructs in FA of living cells. First, I confirm the reliability of the system and show that
insertion into proteins does not influence fluorophore lifetimes. Next, I present cell lines
expressing proteins with a tension sensor and prove that their functionality is not affected
by the linker module. In the last part, effects of protein expression level and point mutations
will be analyzed.
6.3.1 Control probes for lifetime measurements in living cells
Fluorophore lifetimes depend on their surrounding and might be influenced by the insertion
site. Therefore, I measured lifetimes of venus and monomeric Cherry (mCherry) at internal
and C-terminal positions in vinculin and metavinculin (Fig. 6.12 ). For the donor fluorophore
venus lifetime was τD = 2.96 ± 0.04 ns and the acceptor mCherry was measured to decay in
τA = 1.41± 0.03 ns. Position inside the protein did not change fluorescence lifetime and I
could not observe differences between vinculin and metavinculin (Fig. 6.13 B). Obtained
values for the fluorescence lifetime were highly reproducible over a time period of three
years and in good accordance with the literature [131], as well as experiments by other
group members [20].
Next, I measured whether intermolecular energy transfer occurs between adjacent molecules.
Therefore I co-expressed internal or C-terminal constructs of vinculin and metavinculin
with both venus and mCherry tags (Fig. 6.12 A & B). Intermolecular FRET was highest for
internal VV-VC measured inside FA (5.16± 0.1%) and disappeared for C-terminally tagged
VV-VC (0.43± 0.05%) . Values for all other combinations were around 3% (Fig. 6.14 A).
When signal from the whole cell was analyzed, values for intermolecular FRET dropped by
around 2%, indicating that a large contribution for intermolecular FRET is specific to signal
from FA.
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Figure 6.12: Schematic overview of fluorescently tagged vinculin and metavinculin constructs A. Vinculin
and metavinculin with C-terminal venus fluorophore (VV & MV) or internal fluorescence tag (vinculin-
venus(internal) (VVi) & metavinculin-venus(internal) (MVi)). B. Same constructs as shown in A., using
mCherry instead of venus (VC, MC, vinculin-mCherry(internal) (VCi), metavinculin-mCherry(internal) (MCi)).
C. Insertion of the tension sensor (TS) module into vinculin (VTS )or metavinculin (MTS) after the vinculin
head domain (Vh) at position 883. D. Activation sensors (ASs) consist of an internal mCherry tag between
aa 883-884 and a C-terminal venus inserted into vinculin (VAS) or metavinculin (MAS). E. vinculin head
domain (Vh) constructs tagged with C-terminal venus (VHV) and mCherry (vinculin-head-mCherry (VHC)).
All constructs are depicted to scale in units of amino acids.
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Figure 6.13: Lifetime measurement of single flurophores A. Representative normalized photon count mea-
surements of two cells expressing either VV or VC. B. Lifetime measurement for fluorophores venus and
mCherry at internal or C-terminal position in vinculin or metavinculin (n = 47, 59, 30, 58, 32, 29, 32, 32).
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Figure 6.14: Intermolecular controls A. Co-expression of internal or C-terminal tagged venus and mCherry
constructs in vinculin, metavinculin or Vh. Intermolecular FRET is highest for internal vinculin fluorophores
and negligible for C-terminally tagged vinculin. All other constructs yield values around 3%. Additional
expression of EBFP-tagged protein (VB, MB) further reduces intermolecular FRET observed between venus
and mCherry tagged constructs (n = 40, 35, 52, 34, 39, 38, 36 ).
6.3.2 Size and dynamics of FA is not affected by insertion of TS module
Ensuring that insertion of linker peptides does not disturb protein function is crucial for all
biosensor experiments [101]. Even though the VTS has been well studied and characterized
in the past using a different FRET pair [10], we repeated all control experiments for both
VTS and MTS. Full-length TS constructs could rescue the spreading defect of vinc−/− cells,
whereas expression of only vinculin head tension sensor (VHTS) showed impaired spreading
after 120min and increased total FA size for all time-points (Fig. 6.15 A & B). Total adhesion
size per cell after 120min on FN coated glass was determined from accumulated fluorescence
data of FLIM images. Cell lines expressing C-terminal fluorophores or flagelliform peptide
(F40) linker peptides did not show differences in total FA area per cell (Fig. 6.16 A & B).
I performed FRAP experiments for VTS and MTS expressing cells and found increased
stability of MTS compared to VTS at FA (VTS: 93.1± 12.9 s; MTS: 108.2± 9.48 s) (Fig. 6.7 C),
however, the difference was not as pronounced as for VV and MV only (Fig. 6.7 A).
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Figure 6.15: Expression of TS and AS constructs in vinc−/− cells A. Immunostaining of VHTS, VTS and
MTS constructs expressed in vinc−/− cells after 120min on FN, scale bar 20 µm. B. Eccentricity of cells
transfected with TS and AS constructs show rescue of the knockout spreading defect. Cell Mask staining of
live cells after 120min on10 µg/ml FN.
6.3.3 Mean force across MTS is decreased on glass and ESS
The TCSPC-FLIM setup measures bulk fluorescence from all FA inside a cell and yields a
mean value for all molecules. As expected from previous studies [10] seeding cells on FN
coated glass dishes (see 4.5.2) reduced FRET across VTS (14.17± 0.99%) compared to the
VHTS control (18.05± 0.68%). For this study, the most important result was, how tension is
affected by TS insertion into metavinculin. Interestingly, I observed a significant increase
of FRET from MTS (16.26± 0.48%) compared to VTS, suggesting diminished force across
metavinculin (Fig. 6.17 A).
I repeated measurements using the HP35 linker and found a significant reduction of FRET
for both VTS (30.41± 0.19%) and MTS (31.08± 0.09%) compared to VHTS (35.5± 0.31%)
(Fig. 6.17 B). Due to properties of the TS module, which has a shorter length and consists of
the FRET pair YPet/mCherry, overall FRET values are increased leading to a higher dynamic
range and larger absolute differences between measured FRET efficiencies. This data also
shows that a fraction of vinculin and metavinculin molecules are under high enough force
to open up the 6− 8 pNHP35 linker. More measurements and controls using the HP35 and
its stable variant will be needed before this data can finally be interpreted.
To test more physiological conditions of substrate stiffness I seeded VTS and MTS expressing
cells on commercial FN coated ESS with stiffness of 1.5 kPa and 15 kPa, where they exhibited
larger and more elongated FA (see 6.3.2). I observed higher forces across VTS on 1.5 kPa
(10.54± 0.04%) and 15 kPa (11.54± 0.04%), whereas MTS remained unchanged (1.5 kPa :
15.59± 0.04% , 15 kPa : 16.21± 0.02%) (Fig. 6.18 A).
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Figure 6.16: Determination of FA size from live cell images used for FLIM microscopy A. Representative
images of TS constructs used for FLIM measurements from living cells seeded on 10 µg/ml FN on glass or
elastic soft substrates (ESS) of 1.5 kPa and 15 kPa stiffness as indicated. B. Total size of FA per cell remained
constant for expression of VV or MV constructs as compared to TS with either the F40 or villin headpiece
peptide (HP35) linker. An increase in cumulative FA size can be seen for all constructs expressing only the
Vh. Size is significantly increased for co-expression of constitutively active RhoAQ63L and a higher spread is
observed for TS with a HTI mutation.
6.3.4 Control measurements show functionality of TS constructs
To test whether the differences in FRET efficiencies between vinculin and metavinculin were
indeed caused by differences in tension, TS constructs were expressed in a cell line lacking
both talin-1 and talin-2 isoform (talin2xko). As integrins are not activated, these cells are
rounded up and can adhere, but not spread on FN. Due to lower photon counts, the overall
noise level was increased in these measurements; pinhole and magnification were adjusted
to the smaller area of round cells. Differences between FRET efficiencies for TS and control
constructs decreased (VHTS: 15.40± 0.25%, VTS: 13.70± 0.12%, MTS: 15.46± 0.12%) (Fig.
6.19 C). As the variance in this experiment was high, I repeated measurements of VTS and
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Figure 6.17: Analysis of VTS and MTS with F40 and HP35 linkers A. FRET efficiency for TS constructs with
a F40 linker. VHTS serves as a no-force control and shows highest FRET efficiency. Force is increased for VTS
cells seeded on FN and slightly lower for MTS (n = 74, 83, 86 from 4 days). B. Results of TS measurements
using a HP35 peptide as a linker. Again, force is higher for VTS and MTS than for VHTS. The value for the
donor fluorophore YPets was fixed to τD = 3.02 ns (n = 60, 60, 61 from 3 days)
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Figure 6.18: Measurement of TS with F40 linker on ESSs A. Physiological stiffness was achieved by seeding
of cells on FN coated soft substrates with 1.5 kPa and 15 kPa stifness. Force across VTS increased under these
conditions, whereas VHTS and MTS did not show changes (n = 31, 36, 32, 32, 32, 35 from 3 days)
MTS in talin2xko cells which were treated with ROCK inhibitor Y-27632 and increased
acquisition time (Fig. 6.22 B).
As a second control measurement, I introduced a single point mutation (I997A), which has
been shown to disrupt the actin binding surface of vinculin [27]. The result was an increase
of FRET efficiency for VTS-I997A (18.87± 0.01%) comparable to control levels of VHTS,
showing that defective actin interaction leads to drop in forces across vinculin (Fig. 6.19
B).
Together, these control experiments suggest that indeed the enagement with talin on one
side and the F-actin cytoskeleton on the other, is producing the forces measured across TS
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Figure 6.19: Control measurements for tension sensor constructs A. Measurements of F40 TS constructs in
talin2xko cells. Due to the lack of talin no force is sensed across vinculin or metavinculin. Cells remained
rounded and no FA were detected (n = 44, 40, 48 from 3 days). B. Disturbing the actin binding surface of
vinculin by mutating I997A leads to reduced force transduction across VTS-I997A (n = 29, 56 from 3 days).
constructs.
6.3.5 Force across VTS can be increased by additional vinculin or
metavinculin protein
In muscles of the human body, vinculin and metavinculin are co-expressed and it has been
proposed that metavinculin needs to dimerize with vinculin before it can be functional
[44]. Therefore, I wanted to determine whether vinculin affects force transduction across
metavinculin and vice versa.
I co-expressed EBFP-tagged vinculin or metavinculin, which does not spectrally disturb our
measurements, with TS constructs of the other isoform (Fig. 6.20 A & B). Force transduction
was aggravated across VTS in the presence of metavinculin-EBFP (MB) (9.04 ± 0.15%),
whereas MTS did not show increased levels of force upon expression of vinculin-EBFP (VB)
(14.43± 0.06%). As expected, the control probe VHTS, did not exhibit statistically significant
changes and only slightly reduced FRET (16.74± 0.03%), which can be explained by a drop
in intermolecular FRET (Fig. 6.14 A).
From this data, the question arises, whether increasing the total amount of protein has
an influence on tension. When EBFP-tagged vinculin or metavinculin was co-expressed
with the corresponding TS construct, I could again observe increased force across VTS
with additional vinculin (9.75± 0.10%), while MTS with additional metavinculin remained
unchanged (14.77± 0.05%).
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Figure 6.20: Effect of protein stochiometry A. Proteins tagged with EBFP can be co-expressed with TS
constructs without interfering with the FLIM measurements as they are spectrally separated. Expression of
VTS with either VB or MB is shown as an example. Measurements were also performed for MTS and VHTS
together with VB or MB. B. Expressing additional protein significantly increases force across VTS but not MTS
(n = 60, 56, 60, 59, 58 from 3 days).
6.3.6 Affinity between head and tail regulates tension across vinculin
and metavinculin
From the characterization studies of the cell line, I hypothesized that reduced affinity of the
head domain for MVt leads to its increased interaction with talin-1. The working hypothesis
was that force can be shared between multiple active metavinculin molecules binding to
talin-1. Therefore I wanted to increase the proportion of vinculin and metavinculin molecules
in the active states and study, whether lowered HTI has an effect on tension across VTS or
MTS.
A double mutation in the vinculin head (N773A, E775A), which decreases affinity between
head and tail and leads to hypertrophic FA has been described [56]. Upon expression of TS
constructs with HTI mutations, differences in cellular morphology increased and I observed
very small and some extensively large cells and irregularly shaped FAs. In some cells, I also
observed bright protein accumulations, which were excluded from the analysis (see 6.1.2).
Force across VTS-HTI significantly increased and FRET efficiencies for some cells were
even below 5% (VTS-HTI: 7.63± 0.14% vs. VTS: 13.37± 0.03%). For the first time, I also
observed lowered FRET across MTS-HTI, however, the effect was not as pronounced as
for VTS-HTI (MTS-HTI: 14.26± 0.10% vs. MTS: 16.69± 0.10%) (Fig. 6.21 A). Differences
between TS constructs with HTI mutations vanished upon expression in talin2xko cells
(VTS-HTI: 12.72± 0.20%, MTS-HTI: 13.97± 0.05%) (Fig. 6.21 B).
This result shows that force transduction is inherently coupled with HTI interaction of
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Figure 6.21: Analysis of VTS and MTS with HTI mutations A. Introducing a HTI mutation lead to an
inhomogeneous population of cells. This was reflected in the FLIM measurements which revealed higher
spread of FRET efficiencies for both VTS-HTI and MTS-HTI. Mean FRET efficiency was decreased for both
constructs, with a higher effect on VTS (n = 28,76,30,71 from 3 days). B. Control measurements in talin2xko
cells were not significantly different for VTS-HTI and MTS-HTI (n= 54, 64 from 3 days).
vinculin or metavinculin. However, it also indicates that reduced HTI is not sufficient to
explain decreased force across MTS, as higher activation caused by lower HTI leads to
increased force.
6.3.7 Mutation of the gelsolin homology motif in the metavinculin insert
increases force across MTS
As co-expression of vinculin did not lead to increased forces across MTS and lowering the
HTI did not explain the observed reduction of force across MTS, the next step was to analyze
how interaction with F-actin influences force transduction across metavinculin. Therefore, I
tested a hypothesis from Janssen et al. [79], who proposed that a gelsolin homolgy motif in
the metavinculin tail is essential for its interaction with actin.
Residues 936-950 of MVt were compared to the actin binding sequence contained in a
gelsolin peptide (AAIVQLDDYL) [132]. I decided to exchange the putative motif for actin
severing DDY into an aa sequence NTL from the gelsolin like capping actin protein (CapG)
protein which has been shown to gain severing function upon mutation to DDY [133]. It
was exciting to see that the mutated form of MTS indeed bears more tension than before.
Under the same experimental conditions the MTS-gelsolin like capping actin protein (CapG)
mutant (15.96± 0.04%) showed lower FRET than MTS (17.53± 0.01%), but higher FRET
than VTS (14.29± 0.01%) (Fig. 6.22 A). Again, expression in talin2xko cells and treatment
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Figure 6.22: Analysis of MTS with actin interaction mutation A. The CapG mutation DDY947NTL increases
force across MTS-CapG compared to MTS (n = 24, 63, 79). B. Control experiments of MTS-CapG in talin2xko
cells treated with ROCK inhibitor Y-27632 (n = 60, 68, 77 from 3 days).
with ROCK inhibitor or seeding on poly-L-lysine (PLL) restored the same levels for all three
constructs (VTS-ctrl: 14.5± 0.06%, MTS-ctrl:15.21± 0.04% , MTS-CapG-ctrl: 15.18± 0.07%)
(Fig. 6.22 B).
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Figure 6.23: Phosphomimicking mutation of the DDY motif in MTS A. The tyrosine of the metavinculin
DDY motif was mutated to phophomimicking aa A,E,F. No differences between MTS and MTS-DDA, MTS-DDE
or MTS-DDF could be observed (n = 77, 54, 57, 78).
A consequence of this finding was the search for a possible mechanism mediating the
changed force transduction. Early studies on metavinculin proposed a role of the single
additional tyrosine at aa 949 in the MVt insert [134]. Unfortunately, I was not able to confirm
phosphorylation by mass spectrometry as the sequence covering for this region is very poor
due to the low amount of arginine and lysine and high amount of aspartic and glutamic
acid. Mass spectrometry analysis only indicated ubiquitinylation of metavinculin and
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serine phosphorylation at aa S754. Therefore, I mutated Y949 to alanine, phenylalanine and
glutamic acid and expressed TS of these phosphomimicking mutants in cells. However, all
constructs localized normally and no differences in force transduction were observed (MTS:
17.43± 0.04%, MTS-DDA: 17.49± 0.09%, MTS-DDE: 18.20± 0.04%, MTS-DDF: 18.24±
0.03%) (Fig. 6.23). Therefore, I conclude that mutation of only Y949 is not sufficient to
disrupt the mechanism by which force across MTS is decreased and the whole DDY motif
needs to be exchanged.
6.3.8 Summary of tension sensor measurements
On FN coated glass and soft substrates the mean force in FA is reduced for metavinculin
as compared to vinculin. Mean force across VTS increases for co-expression of vinculin or
metavinculin, while MTS is not affected by additional protein. Contrary to the expectation
that force can be shared between multiple active vinculin or metavinculin proteins, lowering
the HTI interaction leads to an increase in force across both VTS and MTS.
Force across MTS could be increased by inserting mutations into the part of the metavinculin
linker, which is thought to mechanically destabilize F-actin. This finding is surprising and
additional experiments will be necessary to understand how the gelsolin homology motif in
the metavinculin linker can reduce force across the protein by interaction with F-actin.
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6.4 Probing interactions of cells with their mechanical
environment
In this last section I want to introduce two biophysical techniques which can be used to
study the influence of metavinculin for interaction with the mechanical environment of the
cell. First, I analyzed the effect of expression of metavinculinon the amount of traction a
cell can actively transduce to an elastic surface. Finally, I performed initial experiments to
combine TCSPC-FLIM with uniaxial cell stretching to measure the influence of an externally
applied mechanical stimulus on TS constructs.
6.4.1 Traction force microscopy (TFM) of vinculin and metavinculin
expressing cells
I measured the amount of deformation which cells generated on an elastic substrate by
Fourier transform traction cytometry (FTTC)-TFM (see sections 2.3.2 & 4.4.2). As TFM has
not been established in the lab before, I needed to optimize parameters like bead size and
color, scan speed and resolution, handling of micropatterns and coating procedure, as well
as seeding and detachment of cells. During this process and for the analysis I received help
from Benedikt Sabass, who had previously published his methods in [112].
The question was, whether metavinculin expression has an influence on the amount of
traction generated by a cell. First measurements on 8 kPa substrates with a low concentration
FN coating (10 µg/ml) lead to a large spread in strain energy values (Fig. 6.25 A). Therefore,
we increased the polyacrylamide (PAA) substrate stiffness to 15 kPa and used 1mg/ml FN
during the sulfo SANPAH photoactivation step, to enhance the attachment and spreading
of cells. Two independent sets of experiments (each at least 15 cells from three different
days) showed that there is no difference in strain energy or traction between VV and MV
expressing cells (median values for traction force VV: 0.435 pJ and 0.427 pJ, MV: 0.519 pJ
and 0.449 pJ, Fig. 6.24 B & Fig. 6.25 B).
For knockout (vinc−/−) and control cells (vinc f/ f ) we could not use fluorescence signal
to determine the distance from the FA to the gel and systematically underestimated the
distance from the substrate, which was determined using transmission light in the brightfield
channel. Total strain energies per cell were lower than for VV or MV cells (vinc f/ f : 0.283 pJ,
n = 33 cells, vinc−/−: 0.278 pJ, n = 28 cells), but there was no significant difference between
both cell lines.
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Figure 6.24: Results of TFM experiments on 15 kPa substrates A. Total strain energy per cell for vinc f/ f and
vinc−/− on 15 kPa substrates. Black circles mark single cells B. Comparison of vinc−/− cells which were
stably transfected with different fluorescently tagged vinculin and metavinculin constructs. C. Cell sizes for
data shown in B., determined by manual tracking of brightfield images.
Next, I wanted to analyze whether metavinculin can alter traction forces in presence of
vinculin and studied cells co-expressing either VV and VC or VV and MC. Overall strain
energy was increased and showed larger variance (VV-VC: 0.858 pJ, n=24 cells, VV-MC:
0.880 pJ, n=19 cells) (Fig. 6.24 B & C).
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Figure 6.25: Comparison of TFM experiments on 15 kPa and 8 kPa substrates A.-B. Strain energy of VV and
MV expressing cells for two different substrate stiffnesses (A.: 8 kPa, B.: 15 kPa) and FN concentrations during
coating. Spread is significantly higher for cells with lower adherence on soft substrates (A.). Dots show single
measurements of individual cells. C.-D. Traction calculated from individual displacement vectors shows no
differences between VV and MV expressing cell lines.
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6.4.2 Combining TCSPC-FLIM with uniaxial cell stretching
To gain further insight about the correlation between intracellular force and externally
applied stretch, I mounted a uniaxial cell-stretching device, which has been built by Prof.
Merkel and colleagues at Forschungszentrum Jülich [110], onto the microscope stage used
for TCSPC-FLIM experiments. Imaging through the bottom of stretch-chambers was only
possible with a long-distance objective (for details of stretch-chamber preparation please
refer to section 4.4.3). I seeded VTS and MTS expressing cells on pre-stretched chambers
and measured around 10 cells for this condition. Next, a stretch of 3mm was applied using
an electronically controlled motor. After re-focusing, I again measured 10 cells and noted
time-points of measurement. To my surprise both VTS and MTS showed an increase in
FRET after the stretching process (VTS: 10.7± 0.3% to 13.4± 0.25% and MTS: 13.5± 0.17%
to 15.1± 0.05% ) (Fig. 6.26 A).
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Figure 6.26: Preliminary results from cell stretching A. FLIM measurement of TS constructs with F40 linker
on polydimethylsiloxane (PDMS) stretch chambers. A linear elastic stretch of 3mm was applied to the stretch
chambers using a motorized stage. Both, VTS and MTS showed an increase in FRET efficiency after 3mm
stretch compared to the unstretched cells. Merged data from three experiments. B. Fluorescence lifetimes for
VV from FA of stretched and unstretched cells. A decrease in lifetime of about 0.1 ns could be seen for a stretch
of 3mm while stretching by 1.5mm lead to a slightly smaller effect. Data from four independent experiments.
To test for confounding factors during the stretching procedure, I seeded cells expressing
only VV and not the TS module and measured lifetime before and after 3mm and 1.5mm
stretch. Even in this control experiment a decrease of donor fluorophore lifetime was seen
(Fig. 6.26 B). Therefore I concluded that substrate stretch induces changes in the fluorescence
lifetime independent of FRET. Further experiments will be required to analyze, which effect
is responsible for the change in lifetime upon stretch and to find methods to calibrate the
system, e.g. by correcting for differences in the donor lifetime.
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7.1 The role of vinculin and metavinculin in focal adhesions
(FAs)
7.1.1 Generation and characterization of new vinculin knockout cells
Over the years, various vinculin knockout cell lines have been established and provide an
indispensable tool to understand its function. Nevertheless, we did not rely on published cell
lines, but generated clonal control and knockout cells (vinc f/ f and vinc−/−) from isolated
mouse embronyic fibroblasts (MEFs) with a floxed vinculin gene to exclude adaptation
effects or side effects of the knockout and ensure a homogeneous population. While
I observed previously described features of vinc−/− cells, like the delayed spreading
phenotype, our cell line maintained their size and formed FAs comparable to vinc f/ f . This
was not surprising, as I took the clonal cell line with the least severe phenotype (clone vinc
−/− #2-1, Fig. 6.1 B) instead of another clone with decreased size (vinc −/− #2-5, Fig.6.1 C).
The effect of vinculin depletion might be more severe for other cell types and I observed a
large variation in cell size and morphology, even for clonal cell lines.
7.1.2 Comparison of metavinculin localization to predictions from in
vitro studies
In mammalian tissue metavinculin is always co-expressed with ubiquitously expressed vin-
culin. It has been proposed that vinculin activated by phosphatidylinositol 4,5-bisphosphate
(PIP2) serves as a co-activator for metavinculin [44, 54]. From the observation that vinculin
tail domain (Vt) and metavinculin tail domain (MVt) form heterodimers, the authors hypoth-
esized that metavinculin can only localize to nascent or mature adhesions in the presence of
full-length vinculin [44]. I showed that metavinculin can localize to FAs, nascent adhesions,
and dorsal ruffles in the absence of vinculin and even takes over part of its function in cell
spreading, adhesion formation, and dynamics. This result shows that insight from truncated
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forms of vinculin in vitro is limited and cellular models are needed to understand protein
function. My results emphasize the role of the tail domain in regulating FA morphology
and spreading dynamics as vinculin head domain (Vh) alone is not sufficient for rescue.
Knock-in of mutated vinculin constructs, such as the Vh domain or head-tail interaction
(HTI) mutations (N773A, E775A), produced more dramatic morphological changes than
vinculin depletion.
At least under the experimental conditions I tested, there are no morphological differences
between vinculin and metavinculin expressing cell lines. This might not be true for all cell
types and it could also be that localization is affected at a scale which is below the resolution
limit of standard fluorescence microscopy, e.g. due to different z-position inside the FA
plaque.
7.1.3 Changes in metavinculin interaction partners and binding affinities
Actin co-sedimentation assays reproduced the previously described finding that both vin-
culin and metavinculin need to be activated, e.g. by Shigella invasin (IpaA), before they
can bind to the actin pellet. I generated a metavinculin activation sensor in analogy to the
previously published vinculin activation sensor [57] to confirm the activation upon binding
to F-actin. Direct measurement of Förster resonance energy transfer (FRET) efficiency via
fluorescence lifetime imaging microscopy (FLIM) from cell lysates provided an elegant way
to characterize activation sensors (ASs) in vitro, which is more accurate than previously used
normalized fluorescence emission spectra [57].
Actin affinities of KD ≈ 5 · 10−7 for both vinculin and metavinculin have been reported
[80], however there is large evidence for differences concerning mechanical stability and
organization of actin by the two isoforms [79, 80]. While earlier studies focused on the
importance of MVt interaction with F-actin, I stress the importance of binding between the
metavinculin head domain and talin-1. From the quantitative mass spectrometry data, it
was estimated that metavinculin binds about 5 fold better to talin-1 than vinculin. This
increased interaction with talin-1 was consistent with manual pull-down experiments.
The large difference in binding of talin-1 was rather surprising, as the amino acid sequence
and structure of both vinculin and metavinculin head domains, which bind to various
vinculin binding sites (VBSs) in the talin rod domain (D1-D4, Fig. 1.4 A-C), are identical.
Most likely, changes in the affinity between metavinculin head and tail domains are the
cause of altered talin-1 binding.
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Surface plasmon resonance measurements of the affinity already reported a lower apparent
affinity of MVt for the head domain compared to Vt (Vt: KD ≈ 5 · 10−8 vs. MVt: Kd ≈
3 · 10−7) due to a change in the association constant (Vt: ka ≈ 1.3 · 105 vs. MVt: ka ≈ 1.5 · 104)
[44]. This HTI interaction seems to be crucial for regulation of vinculin function and more
activated vinculin is found in FA as compared to the cytoplasm [57].
closed actin  bundling
vinculinA B metavinculin
increased  talin
interaction
actin  de-­stabilizationopen
Figure 7.1: Model of binding affinities A. Binding of vinculin molecules to talin (gray) and the F-actin
cytoskeleton (red). A HTI keeps vinculin (green) in a closed conformation which can be weakened by
engagement of the vinculin head with talin. Interaction between the Vt domain and F-actin further stabilizes
the open conformation and enables vinculin to be permanently incorporated into the talin-actin linkage where
it can transduce mechanical forces. B. For metavinculin (orange) I assume a decrease in HTI. This leads to an
increased accessibility of the talin binding domain in the metavinculin head. On the other hand, metavinculin
might destabilize F-actin and therefore actively disengage the talin-integrin from the cytoskeleton.
7.1.4 Interpreting the decreased turnover of metavinculin at FA
Fluorescence recovery after photobleaching (FRAP) decays can be described as limited by
reaction or diffusion rate [128]. In the case of FA molecules I was interested in the reaction
rate, which is on a significantly longer timescale (τ1
2
= 50− 200 s) than the movement of
molecules diffusing freely inside the cell (τ1
2
= 5− 10 s). As I bleach only FA regions, which
are at least 100 times brighter than the surrounding cytomplasm, freely diffusing molecules
will only be present at low numbers. Our setting is therefore not comparable to FRAP
experiments analyzing either membrane-bound or cytomplasmic proteins.
When I analyzed the recovery rates of overexpressed talin and paxillin in vinculin-venus
(VV) or metavinculin-venus (MV) expressing cell lines, there were no effects on turnover
(Fig. 6.6 B & Fig. 6.7 B). Interestingly, the turnover of talin-1 is approximately twice as fast
as for vinculin. This is not only true for our data but has been previously reported [135]: in
contrast to talin, paxillin, focal adhesion kinase (FAK) or zyxin which showed fast turnover,
vinculin is stably bound to FA. According to current opinion, multiple vinculin molecules
are bound to each talin molecule leading to its stabilization in a cooperative manner [136],
which could explain the slower turnover of vinculin compared to talin. Only a small fraction
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of talin-1 is stably bound in FA and as I measured talin-1 and paxillin turnover in presence
of endogeneous protein, the high cytoplasmic signal might mask vinculin or metavinculin
induced changes in stability.
FRAP curves for vinculin on micropatterned substrates were more regular than previously
reported data, which suffered from large spreads due to the dependence of vinculin turnover
on FA size and maturation state [130, 135]. If the amount of protein in the cell is increased,
FRAP recovery is faster. This explains why other groups which express tagged vinculin
constructs on endogeneous background, report significantly shorter recovery times for
vinculin [87, 130, 135].
Metavinculin stability was significantly decreased under two different geometrical conditions
of the micropatterns (X- and Y-shaped). Measurement for 500 s suggest that not only the
initial dynamic is slowed down, but also the immobile fraction is increased. A large fraction
of metavinculin molecules seems to be stably bound in the FA. This is in accordance with the
idea that metavinculin HTI is lowered and more molecules are in the active state. Vinculin
with a T12 mutation, which increases the probability for an open conformation, showed
slower recovery and increased immobile fraction [63].
Some months after the observation that turnover rate is decreased for metavinculin, this
finding was published independently using C2C12 myoblasts [87]. It was suggested that
metavinculin causes stabilization of microfilament anchorage in muscle-specific adhesion,
leading to reduced turnover. However, reduced recovery rates do not necessarily reflect
engagement with the cytoskeleton, as can be seen by the increased lifetime of Vh only and
the actin-binding deficient mutant vinculin-∆In20/21 [96]. I would rather argue that the
link between metavinculin and the F-actin cytoskeleton is weaker than for vinculin and its
strong binding to talin leads to a stabilization which is mostly independent of microfilament
anchorage.
Various attempts have been made to understand how pre-formed clusters of FA molecules
might contribute to their formation and there is evidence that proteins like vinculin, paxillin
and FAK leave the adhesion sites in large aggregates during disassembly [137]. To fully
understand vinculin and metavinculin turnover, it will therefore be necessary to apply
techniques such as correlation spectroscopy and also observe the joint movement with talin
or other FA components [138].
It is also important to note that molecular turnover rates do not allow for calculating overall
stability of adhesion sites, which need to be calculated from unconfined cells and are best
supplemented with information about actin flow [27]. There is a relation between turnover
rates of FA molecules and for example intrinsic time-scale τ for cell re-orientation upon
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cyclic stretch [123], however, the complexity of the adhesome makes it impossible to predict
the effect of a single protein species for the stability of the entire FA.
7.1.5 Influence of posttranslational modifications on metavinculin
function
More than 30 years ago at least eight times higher phosphorylation of metavinculin compared
to avian vinculin was observed by use of 32P-orthophosphate labeling and x-ray detection
[139]. From the sequence of metavinculin we know that there is just one tyrosine (Y949) and
four serines which potentially could be phosphorylated. Two of the serines are located in
the KWSSK motif flanking the metavinculin insert.
It was not possible to analyse the relevant region in the metavinculin using mass spectrome-
try. Comparison with mass spectrometry data from other groups on the Phosphosite page
(www.phosphosite.org) shows that this region is poorly covered during all screens and only
phosphorylation of S972 has been reported.
Phosphomimicking mutant of Y949 did not lead to differences in force (Fig. 6.23), however,
the influence of other sites, like the KWSSK motif flanking the metavinculin insert, still need
to be tested. Besides the active role in force transduction, phosphorylation of Y949 might
also be involved in signaling. I showed that the DDY motif is likely to be involved in the
interaction of MVt with F-actin. Accessibility of this site could therefore be a readout for
mechanical engagement of metavinculin with the cytoskeleton.
7.2 Evaluation of genetically encoded biosensors using
TCSPC-FLIM
7.2.1 Fluorophore calibration measurements and analysis of
intermolecular FRET
I did not observe changes in lifetime of internal vs. terminal fluorophores in vinculin
or metavinculin on fibronectin (FN) coated glass. This also indicates that fluorophore
properties are not affected by forces which act across vinculin or metavinculin. Single
molecule calibration ensured the stability of the villin headpiece peptide (HP35) construct
as no fluorophore unfolding was observed for forces as high as 24 pN over a time period of
5min [20].
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However, changes in donor lifetime seem to occur for FRET measurements on stretched
vs. unstretched polydimethylsiloxane (PDMS) surfaces. Changes of lifetime can occur up
to 100 nm distance from a surface [140]. It requires further testing to determine whether
this effect is responsible for the change in fluorescence lifetime that we observed in PDMS
chambers. Dyes absorbed in PDMS exhibit a big change in lifetime, however, we do not
know about the effects of a PDMS surface [141].
FRET can occur between fluorophores from adjacent molecules. For all biosensor measure-
ments it is therefore crucial to perform adequate control measurements and estimate an
upper boundary for intermolecular FRET. FRET efficiency E depends on the fluorophore
distance as E ∼ 1r6 and it is therefore important that control fluorophores are as close to the
position of actual fluorophores as possible. Indeed, we observed differences between internal
and C-terminally tagged vinculin. Substituting four fluorophores of two adjacent tension
sensors by two proteins with an internal fluorophore of the two different colors systemati-
cally underestimates intermolecular FRET. On the other hand internal fluorophores might
be closer than fluorophores of tension sensor (TS) modules. Therefore our measurements
only provide an estimate for intermolecular FRET (Fig. 6.14).
7.2.2 Measurement of FRET signal from FA of living cells
While many other laboratories rely on ratiometric methods to determine FRET efficiencies
inside living cells, I decided to establish a lifetime-based approach. FLIM is independent of
fluorescence intensity and allows for direct calculation of FRET efficiencies, but provides
lower temporal and spatial resolution.
From single molecule calibration, the response of linker peptides to the applied piconewton
(10−12N) (pN) forces is known, however, bulk measurement of fluorescence signal does
not allow to discern between different states. Therefore, I can only determine a mean
FRET efficiency without any access to the underlying distribution of states. It is therefore
important to measure signal from several (e.g. 20) cells and 3-5 repeats per construct to equal
out effects of cell morphology and differences in expression levels. To directly compare two
constructs they should be measured on the same day and under exactly the same conditions.
It is advisable to always measure a control consisting of only the donor fluorophore to
exclude systematic errors in the measurement.
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7.3 Factors contributing to force transduction across TS
constructs
Force across metavinculin tension sensor (MTS) seems to be less than across vinculin tension
sensor (VTS). This effect was especially pronounced on elastic soft substrates (ESS) and
vanished upon expression in cell lacking both talin-1 and talin-2 (Fig. 6.18 A & Fig. 6.19 A).
Several mechanisms have the potential to modulate force transduction across metavinculin
(Fig. 7.2 B-D):
• Metavinculin could bind VBSs on talin independent from engagement with the actin
cytoskeleton.
• Insertion of metavinculin molecules could lead to a reduction of force by distributing
it across multiple proteins.
• Direct interaction between metavinculin tail domain and F-actin could destabilize
filaments.
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DC
force  transduction  across  vinculin metavinculin  binding  to  talin  without  
cytoskeletal  engagement
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Figure 7.2: Models explaining reduced force across metavinculin A. Vinculin (green) is bound to both talin
(gray) and the F-actin cytoskeleton (red). The domains of talin which are reoriented upon binding to vinculin
and F-actin are shown in yellow. B.-D. depict models how reduced force across metavinculin (orange) could
be explained: B. Metavinculin head domain bind talin without engaging to the F-actin cytoskeleton, thus
blocking cytoskeletal linkages and reducing force. C. Parallel insertion of metavinculin molecules leads to a
reduced mean force across the proteins. D. The MVt insert affects actin stability and reduces the force which
can be beared by the linkage. This mechanism could be mediated by severing as well as changes in actin
persistence length or bundling properties.
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Using various TS constructs I tried to distinguish between the contribution of different
factors to the force transduction across both VTS and MTS. In the following section, I will
discuss, how expression of additional protein, engagement with the F-actin cytoskeleton,
and altered HTI contribute to the modulation of mechanical force across vinculin and
metavinculin.
7.3.1 Total amount of protein and turnover rates
Expression levels of vinculin and metavinculin show complex regulation, which in vivo can
be modulated by factors as different as development, pregnancy, application of external
forces or disease (see 1.3.5). In flies it has also been shown that overexpression of vinculin
influences cardiac architecture and increases the life span of animals [97].
In the fibroblast model I mimicked the effect of different amount of protein using co-
transfection of constructs in a modified pLPCX (pLPCXmod) expression vector system.
Western blots confirmed that the expression level of VV or MV constructs were comparable
to vinculin levels of floxed (vinc f/ f ) cells (Fig. 6.3 A).
FRAP experiments show that increasing the amount of protein leads to faster turnover rates
and higher mobile fractions for both vinculin and metavinculin but the difference between
the isoforms is even more pronounced and the effect on metavinculin turnover is weaker
(Fig. 6.6). Faster turnover can be explained by faster re-binding of protein to unoccupied
binding sites, e.g. on talin molecules. It is important to keep in mind that talin binding is
important for (meta)vinculin localization at FA, but other binding partners like PIP2 and
unbound molecules also contribute to the observed FRAP signal.
The TS experiments show that force across VTS increases upon expression of additional
vinculin or metavinculin, whereas force across MTS does not seem to be affected (Fig. 6.20
B). From immunoprecipitation experiments we know that 5-times more metavinculin is
bound to talin-1 (Fig. 6.9 A & B). This suggests that there is still a large potential for vinculin
to occupy additional binding sites on talin-1.
Data from single-molecule experiments lead to the conclusion that vinculin binds to talin
in a cooperative manner and one binding triggers a series of other events [136]. Therefore
a relatively moderate increase of vinculin concentration could already have a large effect
on protein recruitment. It is also known, that once vinculin binds to talin-1 and is actively
engaged with the actin cytoskeleton, previously cryptic VBSs open up [31, 32].
On the other hand, metavinculin binding to talin-1 could already be close to saturation
and therefore might not be affected by expression of additional protein. However, it seems
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that the presence of metavinculin does not alter the amount of force transduced across VTS
compared to additional vinculin.
7.3.2 Association with the F-actin cytoskeleton
Introducing mutations into TS constructs enabled me to further understand how actin
binding contributes to force transduction. The actin binding mutation I997A, which has been
first described by [27], dramatically decreased force across VTS. An additional experiment
to test the effects of F-actin binding on force across VTS would be mutation V1001A, which
has been described to have an intermediate affinity [78].
Since the beginning of this thesis, two major contributions have been made by others to
our understanding of how the metavinculin tail insert affects F-actin organization: in 2012
Janssen et al. [79] proposed that metavinculin promotes actin severing, however three years
later this view was challenged by the observation that actin fragmentation does not occur in
real time assays [80]. To date the most convincing conclusion from in vitro studies is that
metavinculin results in a 2-fold reduced actin persistence length lp, but does not lead to the
sufficient structural changes to sever F-actin [80].
In immunostainings I did not observe changes in the global F-actin structure for cells
expressing VV or MV, however, this does not exclude local changes. Measurement of the
actin dynamics was beyond the scope of this thesis but in accordance with the molecular
clutch hypothesis my prediction is that metavinculin is not able to slow down the retrograde
flow of F-actin as much as vinculin does [27].
Comparison to other actin severing proteins reveals a 47% identity between gelsolin and the
metavinculin insert from position 936-950 [79]. This region also contains the actin binding
motif AAIVQLDDYL [132]. Interestingly, there is a gain of function mutation, which enables
the only non-severing member of the gelsolin family CapG to sever actin [133]. I used this
information about the CapG amino acid sequence to design my own metavinculin mutant.
Forces across MTS increased upon change of DDY to the non-severing NTL motif from the
CapG amino acid sequence, indicating the importance of this region for mechanotransduc-
tion. This mutation of metavinculin has not been described in the literature before and has
the potential to contribute to our understanding of fundamental differences between active
severing and induction of mechanical discontinuities leading to actin fragmentation. This is
also crucial to understand other severing molecules like ADF/cofilin [80]. Cryo-electron mi-
croscopy (EM) on the lamellipodia of VV and MV or superresolution microscopy could give
insight into the size distribution and bending of actin filaments close to FA. In combination
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with actin speckle miscroscopy, the relevance of metavinculin and especially the DDY motif
for F-actin bundling might further be elucidated.
7.3.3 Effects of the HTI on force transduction
The HTI mutations severly affected FA and cell morphology for both vinculin and metavin-
culin, indicating large scale effects on FA and cytoskeletal organization. I observed hyper-
trophic FA, which were not able to disassemble and some cells showed protein accumula-
tions.
While it is widely accepted that vinculin activation state is important for its localization and
function at FA [25], it was not clear how the HTI interaction affects force transmission. I can
state that force increases across both VTS and MTS when HTI is lowered (Fig. 6.21). This
is the only experiment in which we observe FRET efficiency values for the MTS between
5− 10%, which shows that it is indeed possible to increase the mean force across MTS.
Similar to vinculin overexpression, increasing the amount of active vinculin protein could
lead to a reinforcing effect caused by cooperative binding to talin.
7.3.4 Implications of reduced force transduction across metavinculin
Metavinculin expression could either provide resistance against external mechanical stimuli
or uncouple the acto-myosin machinery from adhesion sites. It is stabilized at FA and could
therefore also increase the stability of the talin scaffold and thus the remaining adhesion
site.
Evidence accumulates that metavinculin indeed uncouples adhesion plaques from the
cytoskeleton. This could either prevent high actomyosin generated forces to tear apart the
adhesion or limit the size and strength of actin bundles, which could otherwise inhibit
disassembling of adhesions and ultimately cause cells to be incapable of remodelling and
migration.
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8.1 Future directions in the analysis of molecular biosensors
8.1.1 Measurements using linker peptides with different force regimes
As pointed out in the introduction, calibration of the linker peptide used for the tension
sensor is necessary for the quantification of force. The mechanical properties of proteins
can be determined using methods like atomic force microscopy (AFM) or optical traps.
For this study, I used flagelliform peptide (F40) and HP35 linker, but other linkers can be
employed as well. A stable form of the HP35 containing a point mutation shifs the highest
force sensitivity to 9− 11 pN [20] is currently tested to determine whether VTS and MTS
are under high enough force to open up the stiff sensor. Using sensors with a higher initial
FRET ratio should further increase our measurement precision [142].
8.1.2 Extending measurements to three-dimensional substrates
Over the last decades studying cell adhesion predominantly focused on the huge streak-like
focal adhesion structures appearing when single cells spread on a solid extracellular matrix
(ECM) coated support. This work is no exception and it is valid to generate experimental
conditions which allow for sufficient amount of signal and enable the use of techniques
such as total internal reflection microscopy (TIRF). However, the morphology which cells
acquire under these conditions should not be overestimated as a read-out parameter and
may be completely different in tissues, where forces are balanced between neighboring cells.
Indeed, it has been shown that the effect of vinculin knockout on cell migration is reversed
in three-dimensional collagen matrices with wildtype cells being three times more invasive
than vinc−/− [143]. Vinculin seems to be important for the formation of protrusions and
increasing persistence during cell migration in three-dimensional environments [144].
Another aspect which was at least partially adressed in this study, is the influence of
substrate stiffness on cell differentiation and growth. I performed control experiments for
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our TS measurements on 1.5 kPa and 15 kPa, however, under normal culture conditions cells
were grown on plastic dishes. Future experiments could be optimized by growing cells on
surfaces coated with PDMS or a similar elastic support over a longer time before analysis.
8.1.3 From whole cell analysis to force measurements at the adhesion
level
Adhesions are dynamic structures with protein compositions depending on their history
(nascent or assembling vs. disassembling) and position inside the cell. Within an adhesion
proximal, central, and distal parts can be distinguished and a FA belt surrounding the
adhesion sites exists. One mechanism, which has been proposed to structure adhesion sites,
is the segregation of different integrin subtypes into separate clusters.
Over the past years, the VTS was adapted by various groups to measure how FA position
and history influences intramolecular force. The most exhaustive analysis of the relationship
between FA size and vinculin tension, including a theoretical model, was performed by [83].
They discovered a complex multi-modal behavior of correlations and distinguished force
and size regimes with different properties. For example, force positively correlates with size
in mid-sized FA whereas it shows a negative correlation in small and very large adhesions
Hernandez-Varas et al. [83].
Compared to ratiometric FRET, lifetime imaging only provides a limited spatial and temporal
resolution. Therefore analysis of FLIM data presented here does not take size and position
of FA into account but averages over all adhesions.
Based on the observation that tension across MTS shows a lower variance between cells and
is not influences by protein stochiometry I predict a weaker correlation of FA history and
molecular tension. Indeed, comparing VTS, MTS and vinculin head tension sensor (VHTS)
using ratiometric FRET and the analysis algorithms of Hernandez-Varras et al. [83] might
give us further inside into metavinculin function. It would be interesting to know, whether
MTS is independent of increase in FA area for parameter regions in which VTS shows a
strong correlation.
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8.2 Linking FA mechanotransduction to protein translation
and alternative splicing
The story of metavinculin has always been fascinating because of the intriguingly complex
expression level, which depends on cell type, mechanical stimulation, and other factors
discussed in section 1.3.5. Studying how alternative splicing of the metavinculin isoform is
regulated, would therefore greatly contribute to our understanding of the genetic foundation
of mechanotransduction. Indeed, various pathways like MAPK, Wnt or MKL1/Srf signaling,
link integrin adhesions to nuclear activity and a direct physical connection via the LINC
(nesprin and SUN proteins) exists [145].
A B
Figure 8.1: The role of vinculin in genetics A. Connections between FA sites and the nucleus. A direct
physical link between the actin cytoskeleton and the nuclear membrane is mediated by nesprins and SUN
proteins. This connection allows mechanical signals to directly reach the nucleus [145]. B. Illustration of the
predicted role of Raver-1. It is present in the nucleus and the cytoplasm where it binds to activated vinculin
which locks it at FA. This vinculin/Raver-1 complex could now bind mRNA and promote localized translation
[146].
A second interesting topic is how local mRNA translation might be differentially regulated
by vinculin and metavinculin. It was first proposed by Lee et al. [39] that activated vinculin
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interacts with Raver-1 which could lead to production of FA components directly at adhesion
sites [146]. The same group observed that metavinculin is capable of binding Raver-1 even
in its closed state [40], opening up the possibility for an isoform-specific regulation of on-site
transcription.
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9 Summary
By generating metavinculin expressing cell lines and measuring intracellular forces with
tension sensor (TS) constructs, I was able to approach the question how the 68 aa insert
in the tail region alters protein function. Metavinculin is indeed able to take over part of
vinculin functions at FAs where it localizes and can rescue spreading. I did not observe
significant morphological differences between vinculin and metavinculin expressing cell
lines, however, fluorescence recovery after photobleaching (FRAP) and mass spectrometry
experiments revealed a reduced turnover of metavinculin and higher affinity for talin.
The main experimental challenge of this project was to set-up a pipeline for acquiring and
evaluating time-correlated single photon counting (TCSPC)-fluorescence lifetime imaging
microscopy (FLIM) data of Förster resonance energy transfer (FRET) constructs. Custom-
written programs for analysis of FRET signal from FA are now routinely used by others. A
metavinculin tension sensor (MTS) was generated in analogy to the previously published
vinculin tension sensor (VTS) [10] and I observed decreased mean force across metavinculin
for a range of substrate stiffnesses (fibronectin (FN) coated glass, 1.5 kPa, 15 kPa).
Force across metavinculin does not increase in the presence of vinculin, whereas vinculin
force is aggravated upon increased expression of both vinculin and metavinculin. Therefore,
I propose, that force is not shared between molecules but a different mechanism needs to
reduce force across MTS.
Head-tail interaction (HTI) of metavinculin is lowered and it can therefore be kept in an
open conformation and bind to talin, which enhances its stability in FAs. Furthermore,
metavinculin seems to actively modulate F-actin binding by inducing mechanical instability
through a gelsolin-like homology domain containing a DDY motif. It could therefore be
used to reduce but not completely abolish transmission of forces from the cytoskeleton to
the FA plaque. Further investigation is needed to reveal, how metavinculin changes actin
flow rates and filament structure inside the cell.
To understand the role of metavinculin for the cell’s interaction with its environment, I
measured traction forces and subjected TS expressing cells to uniaxial stretching. However,
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measuring changes in intracellular force upon external stretch will require further calibration
measurements.
The main challenge for the future will be to translate our findings in vivo and find out more
about the physiological role of metavinculin with a focus on its role in the development of
disease. On the other hand, single molecule analysis of FRET biosensors in living cells will
open up doors for a new understanding of protein dynamics. Molecular TS have proven
to be powerful tools to unravel details of mechanotransduction, but only the knowledge of
force distribution across individual proteins will unleash its whole strength.
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10 Supplementary Material
10.1 Directory of used chemicals and antibodies
Laboratory equipment and pipetting material were supplied by Sarstedt, Schubert & Weiss,
Kisker, Eppendorf and VWR. Restriction enzymes and buffers were purchased from New
England Biolabs GmbH (NEB) and used according to manufacturers information. Common
chemicals were purchased from Roth, Sigma or Life Technologies.
10.1.1 Materials for biochemistry
Product name Supplier Cat. No.
µ Columns Miltenyi 130-042-701
µ MACS GFP Tagged Protein Isolation Kit Miltenyi 130-091-125
µ MACS HA Tagged Protein Isolation Kit Miltenyi 130-091-122
BCA Protein Assay Kit Merck 71285-3
cOmplete ULTRA, mini, EDTA-free EASYpack Roche 05892791001
Homogenizer 2ml Dounce VWR SCERSP885300-
0002
Immobilon Western Chemilumineszenz HRP
Substrat
Merck WBKLS0500
Immobilon-P Rolle Merck IPVH00010
Skim milk powder AppliChem A0830.0500
Mini-PROTEAN TGX Gels, 4− 15%, 30 µl Biorad 456-1083
PhosStop Roche 04906837001
Ponceau S solution for electrophoresis (0.2%) Serva 33427.01
Prestained Protein Ladder (10− 230 kDa) NEB P7710S
Prestained Protein Marker, Broad Range, pre-
mixed
NEB P7708L
Restore Plus Western Blot Stripping Buffer Fisher Scientific 10016433
Table 10.1: Materials for biochemistry
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10.1.2 Materials for cell culture
Product name Supplier Cat. No.
Blebbistatin Sigma B0560
µ-Dish 35 mm, ESS 1.5 kPa Ibidi 81291
µ-Dish 35 mm, ESS 15 kPa Ibidi 81391
0.5% Trypsin-EDTA (10X), no Phenol Red Life Technologies 15400054
BrdU Cell Proliferation Assay Merck QIA58-200TEST
Calyculin A Sigma C5552-10UG
Chloroquine diphosphate crystalline Sigma C6628
CYTOOchips 20x20 Starter’s FN CYTOO 10-900-10-06
CYTOOchips 20x20 Y-M-FN CYTOO 10-011-10-06
DMEM, High Glucose, GlutaMAX, Pyruvate Life Technologies 31966047
DMEM/F-12, GlutaMAX Supplement Life Technologies 31331028
Fibronectin, Bovine Plasma Merck 341631-5MG
Lipofectamine 2000 Transfection Reagent Life Technologies 11668027
Opti-MEM I Reduced Serum Medium, Gluta-
MAX Supplement
Life Technologies 51985026
PBS Tabletten Sigma P4417-100TAB
Penicillin-Streptomycin (10,000 U/mL) Life Technologies 15140122
Polybrene Infection/Transfection Reagent Merck TR-1003-G
Poly-L-Lysine 0.01% solution mol. wt. 70,000-
150,000
Sigma P4707-50ML
Y-27632 Sigma Y0505
Zählkammer Neubauer Improved H/l O.kl. VWR 630-1509
Table 10.2: Materials for cell culture
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10.1.3 Materials for molecular biology
Product name Supplier Cat. No.
Alkaline Phosphatase CIP NEB M0290L
Ethidium bromide solution 1% Roth 2218.1
LB Agar (Luria/Miller), granulated Roth 6675.2
mi-Plasmid Miniprep Kit Metabion mi-PMN250
NucleoBond Xtra Midi Plus Macherey-Nagel 740412.50
NucleoSpin Gel and PCR Clean-up Macherey-Nagel 740609.250
PfuUltra (TM) II Fusion HS DNA Polymerase,
200 rxn
Agilent 600672
Quick-Load 1 kb Extend DNA Ladder NEB N3239S
QuikChange II Site-Directed Mutagenesis Kit Agilent 200523
SmartSeq Kit Eurofins MWG 26000521
T4 DNA Ligase NEB M0202L
UltraPure Agarose Life Technologies 16500500
Table 10.3: Materials for molecular biology
10.1.4 Materials and equipment used for microscopy
Product name Supplier Cat. No.
BrightLine HC 514/30 AHF F37-514
BrightLine HC longpass-filter 593/LP AHF F37-594
Bandpass ET 545/30 AHF F49-545
Bandpass ET 690/50 AHF F47-690
ProLong Gold antifade reagent Life Technologies P36934
Rose Bengal dye Sigma R3877
Table 10.4: Materials and equipment used for microscopy
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Antigene Species Label Source Cat No. IF WB
α-catenin rabbit - Sigma C2081 1/500
α-Tubulin
(37B5)
rat - Synaptic
Systems
302217 1/20.000
β-catenin mouse - Sigma C 7207 1/500
DAPI 1/10.000
desmin 1/200
FAK rabbit - Milipore 06-543 1/1.000
GAPDH
(6C5)
mouse - Calbiochem CB1001 1/10.000
GFP rabbit - abcam ab290 1/2.000
GFP
(GSN149)
mouse - Sigma G1546 1/2.000
HA-Tag (6E2) mouse Alexa
647
Cell Sig-
naling
3444
HA-Tag (6E2) mouse Alexa
647
Cell Sig-
naling
3444 1/2.000
mCherry
[1C51]
mouse - abcam ab125096 1/2.000
Metavinculin
tail [6E3]
mouse - BSBS 1/10
Mouse IgG chicken Alexa
488
Invitrogen A-21200 1/400
Mouse IgG goat HRP Biorad 170-6516 1/10.000
N-Cadherin rabbit Epitomics 2447-1 1/500
Paxillin mouse - BD 610051 1/400 1/2.000
Phalloidin toxin Alexa
488
Invitrogen A12379 1/400
Phalloidin toxin Alexa
647
Invitrogen A22287 1/200
P-Tyrosine
[4G10]
mouse - Millipore 05-321 1/2.000
Rabbit IgG chicken Alexa
488
Invitrogen A-21441 1/400
Rabbit IgG goat HRP Biorad 170-6515 1/10.000
Rat IgG goat Alexa
568
Invitrogen A11077 1/400
sm-actin mouse Cy3 Sigma C6198 1/200
Talin (8d4) mouse - Sigma T3287 1/400 1/2.000
Talin-1
[mono]
mouse - abcam ab57758 1/2.000
Tubulin
(DM1A)
mouse - Sigma T9026 1/5.000
Vimentin 1/200
Vinculin mouse - Sigma V9131 1/400 1/10.000
Vinculin-
pY1065
rabbit - Invitrogen 44-1078G 1/1.000
Table 10.5: Used antibodies and dilutions
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10.1.5 Materials used for biophysical experiments
Product name Supplier Cat. No.
Acrylamide 40% solution Sigma A4058-100ML
Acrylamide/Bis Solution, 37.5:1 (30% w/v) Serva 10688.03
Dow Corning High-Vacuum Silicone Grease Sigma Z273554-1EA
FluoSpheres Carboxylate-Modified Micro-
spheres, 0.04 µm, red-orange fluorescent
(565/580)
Life Technologies F8794
FluoSpheres Carboxylate-Modified Micro-
spheres, 0.2 µm, crimson fluorescent (625/645)
Life Technologies F8806
TEMED Serva 35930.02
Ph-indicator stripes VWR 1.09533.0001
Sulfo-SANPAH Fisher Scientific 10474005
Sylgard 184 Elastomer Kit VWR 634165S
Table 10.6: Materials used for biophysical experiments
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10.2 Directory of oligonucleotides and cloned constructs
10.2.1 Oligonucleotides
No. description sequence
C1 vinc PCR primer ApaI forward ATA GGG CCC ACC ATG CCA GTG
TTT CAT ACG CGC ACG ATC G
C2 vinc PCR primer XbaI STOP re-
verse
CGC TCT AGA CTA CTG GTA CCA
GGG AGT CTT TCT AAC C
C3 vinc PCR primer XbaI noSTOP
reverse
CGC TCT AGA CTG GTA CCA GGG
AGT CTT TCT AAC C
C30 vinc PCR primer overlap PCR
SalI-NotI linker 883
CGC GGC CGC ATA TAT GTC GAC
TTC ATC CTT TTC CTC TGG TG
C31 vinc PCR primer overlap PCR
SalI-NotI linker 884
ATA GTC GAC ATA TAT GCG GCC
GCG GAG TTC CCT GAG CAG AAG
GC
C32 vinc PCR primer NotI forward ATG CGG CCG CGG AGT TCC CTG
AGC AGA AGG CCG G
C33 vinc PCR primer NotI STOP for-
ward
CAT GCG GCC GCC TAC TGG TAC
CAG GGA GTC TTT CTA ACC
C48 vinc PCR primer AvrII forward CCT CCA CCT AGG CCT CCA CCA
CCA GAG GAA
C15 vinc QuikChange L234V for-
ward
GAA GCT TTA AAA AAT CGC AAT
TTT ACT GTA GAA AAA ATG AGT
GCT GAA ATT AAT G
C16 vinc QuikChange L234V reverse CAT TAA TTT CAG TCA TTT TTT
CTA CAG TAA AAT TGC GAT TTT
TTA AAG CTT C
C17 vinc QuikChange K142E for-
ward
AGA GTT TGC AAA GGA ATT TTG
GAA TAT CTT ACA GTG GCA GAG
G
C18 vinc QuikChange K142E reverse CCT CTG CCA CTG TAA GAT ATT
CCA AAA TTC CTT TGC AAA CTC
T
C34 vinc QuikChange N773A/E775A
forward
GCT AAG AGG GAG GTG GAG GCT
TCC GCG GAT CCC AAG TTC CGT
GAG GCT GT
C35 vinc QuikChange N773A/E775A
reverse
ACA GCC TCA CGG AAC TTG GGA
TCC GCG GAA GCC TCC ACC TCC
CTC TTA GC
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No. description sequence
C42 vinc QuikChange L277M for-
ward
ATT GGC CTC CAT AGA CTC CAA
AAT GAA CCA GGC CAA AGG TTG
GCT CCG TG
C43 vinc QuikChange L277M reverse CAC GGA GCC AAC CTT TGG CCT
GGT TCA TTT TGG AGT CTA TGG
AGG CCA AT
C46 vinc QuikChange T12 forward GCC AAG CAG TGC ACA GCT GCA
GCG ATT GCA ACC AAC CTC TTA
CAG G
C47 vinc QuikChange T12 reverse CCT GTA AGA GGT TGG TTG CAA
TCG CTG CAG CTG TGC ACT GCT
TGG C
C73 vinc QuikChange I997A fwd GCA CCC AGC TCA AAG CCC TGT
CCA CAG TGA AGG
C74 vinc QuikChange I997A bkwd CCT TCA CTG TGG ACA GGG CTT
TGA GCT GGG TGC
C20 metavinc QuikChange A934V
forward
GAG GCA GAT GCG GTC GAT GCT
GCT GGC
C21 metavinc QuikChange A934V re-
verse
GCC AGC AGC ATC GAC CGC ATC
TGC CTC
C24 metavinc QuikChange R975W
forward
CGC GGC TCA GTC CTT GCA TTG
GGA AGC TAC
C25 metavinc QuikChange R975W
reverse
GTA GCT TCC CAA TGC AAG GAC
TGA GCC GCG
C66 metavinc QuikChange
DDY947DDA forward
GAC ATG GAA GAC GAT GCC GAA
CCT GAG CTG CTG
C67 metavinc QuikChange
DDY947DDA reverse
CAG CAG CTC AGG TTC GGC ATC
GTC TTC CAT GTC
C68 metavinc QuikChange
DDY947DDE forward
GAC ATG GAA GAC GAT GAG GAA
CCT GAG CTG CTG
C69 metavinc QuikChange
DDY947DDE reverse
CAG CAG CTC AGG TTC CTC ATC
GTC TTC CAT GTC
C70 metavinc QuikChange
DDY947DDF forward
GAC ATG GAA GAC GAT TTC GAA
CCT GAG CTG CTG
C71 metavinc QuikChange
DDY947DDF reverse
CAG CAG CTC AGG TTC GAA ATC
GTC TTC CAT GTC
C62 metavinc primer overlap NotI
forward
CTG TAC AAG GCG GCC GCG GAG
TTC CCT G
C63 metavinc primer overlap NTL re-
verse
GGT TCC AAA GTG TTT TCC ATG
TCA GGG GGG ACA GGG AAG
CCA GCA GCA TCG GCC G
C64 metavinc primer overlap NTL
forward
GGA AAA CAC TTT GGA ACC TGA
GCT GCT GTT AAT GCC ATC CAA
TCA GCC GGT CAA C
C4 vinc sequencing primer 1 CTT GGG CCA GAT TGA CGA G
C36 vinc sequencing primer 2 GCC TGG GCC AGC AAG GAC AC
C6 vinc sequencing primer 3 ACA GTG GAT GAC CGT GGA GT
C7 vinc sequencing primer 4 AGC TGC TTA TGA ACA TTT TGA
GA
105
10.2 Directory of oligonucleotides and cloned constructs
No. description sequence
C8 vinc sequencing primer 5 AGA CCT TGA ACA ACT CCG ACT
AAC
C9 vinc sequencing primer 6 CTG CTG ATG GCT GAG ATG TC
C14 vinc sequencing start reverse CAG AGA GGA TGC CCC TTG ACC
C
C59 vinc sequencing VFC CCC GGC CTT CTG CTC AGG GA
C10 venus PCR primer XbaI forward GGC TCT AGA GGA GGG ATG GTG
AGC AAG GGC GAG GAG C
C11 venus PCR primer NotI STOP
reverse
ATA AGC GGC CGC TTA CTT GTA
CAG CTC GTC CAT GCC G
C57 venus QuikChange Y66L for-
ward
ACC ACC CTG GGC TTA GGC CTG
CAG TGC TTC GC
C58 venus QuikChange Y66L reverse GCG AAG CAC TGC AGG CCT AAG
CCC AGG GTG GT
C19 mCherry Polymerase Chain Re-
action (PCR) primer XbaI for-
ward
GGC TCT AGA ATG GTG AGC AAG
GGC GAG GAG G
C55 mCherry QuikChange Y71L for-
ward
CCC TCA GTT CAT GTT AGG CTC
CAA GGC CTA CG
C56 mCherry QuikChange Y71L re-
verse
CGT AGG CCT TGG AGC CTA ACA
TGA ACT GAG GG
C49 TagBFP PCR primer XbaI for-
ward
ACC AGT CTA GAG GAG GGA TGA
GCG AGC TGAT T
C50 TagBFP PCR primer NotI STOP
reverse
GCG GTG GGC GGC CGC TTA ATT
AAG TTT GTG CC
C28 PCR primer pBSK∆NotI MCS
forward
GGC CCG CAC CGC GGT GGT CAC
CGC GAG CT
C29 PCR primer pBSK∆NotI MCS re-
verse
CGC GGT GAC CAC CGC GGT G
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10.2.2 Cloned cDNA constructs
No. plasmid description abbreviation
156 pBSK + vinculin
157 pBSK + metavinculin
161 pBSK + vinculin-venus
162 pBSK + metavinculin-venus
167 pLPCXmod + metavinculin-venus.STOP MV
168 pBSK + metavinculin-mCherry.STOP
169 pLPCXmod + metavinculin-mCherry.STOP MC
172 pLPCXmod + vinculin-venus.STOP VV
177 pLPCXmod + metavinculin (R975W)-venus MV-RW
178 pLPCXmod + metavinculin (A934V)-venus MV-AV
199 pBSK +vinculin-mCherry.STOP
204 pBSK-∆N + vinculin (head)
212 pLPCXmod + vinculin-mCherry.STOP VC
213 pBSK-∆N + metavinculin with SalI-NotI linker
214 pBSK-∆N + vinculin with SalI-NotI linker
215 pLPCXmod + venus-F40-mCherry.STOP TS
223 pLPCXmod + vinculin (head)-[venus-F40-mCherry].STOP VHTS
227 pLPCXmod + vinculin (head)-[venus-F40-mCherry] (NoS-
top)
229 pBSK + metavinculin(R975W)-venus
234 pLPCXmod + metavinculin-[venus-F40-mCherry] (internal) MTS
235 pLPCXmod + metavinculin (R975W)-[venus-F40-mCherry]
(internal)
RTS
236 pBSK + metavinculin(A934V)-venus
237 pBSK-∆N + vinculin-venus (internal)
238 pBSK-∆N + vinculin-mCherry (internal)
250 pLPCXmod + vinculin(front; ApaI-EcoRI)
254 pLPCXmod + vinculin-[venus-F40-mCherry] (internal) VTS
255 pLPCXmod + metavinculin (A934V)-[venus-F40-mCherry]
(internal)
263 pLPCXmod + vinculin(head)-venus (NoStop)
264 pLPCXmod + vinculin(head)-mCherry (NoStop)
265 pLPCXmod-∆CMV + metavinculin-[venus-F40-mCherry]
(internal)
267 pLPCXmod + vinculin-venus (internal) VVi
268 pLPCXmod + vinculin-mCherry (internal) VCi
287 pLPCXmod + vinculin-mCherry (internal)-venus.STOP VAS
288 pLPCXmod + metavinculin-mCherry (internal)-venus.STOP MAS
303 pLPCXmod + metavinculin (R975W)-mCherry (internal)-
venus.STOP
RAS
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366 pLPCXmod + vinculin (N773A, E775A)-mCherry (internal)-
venus.STOP
VAS-HTI
367 pLPCXmod + metavinculin (N773A, E775A)-mCherry
(internal)-venus.STOP
MAS-HTI
368 pLPCXmod + metavinculin (R975W, N773A, E775A)-
mCherry (internal)-venus.STOP
389 pLPCXmod + metavinculin-mCherry(internal) MCi
401 pBSK + vinculin(L277M) (NoStop)
405 pLPCXmod + vinculin (L277M)-mCherry (internal)-
venus.STOP
406 pLPCXmod + vinculin (N773A, E775A)-[venus-F40-
mCherry] (internal)
VTS-HTI
407 pLPCXmod + metavinculin (N773A, E775A)-[venus-F40-
mCherry] (internal)
MTS-HTI
420 pLPCXmod + vinculin (N773A, E775A)-venus.STOP VV-HTI
421 pLPCXmod + metavinculin (N773A, E775A)-venusSTOP MV-HTI
431 pLPCXmod + metavinculin-venus (internal) MVi
435 pBSK + vinculin-[venus-F40-mCherry].STOP
436 pBSK + metavinculin-[venus-F40-mCherry].STOP
437 pLPCXmod + vinculin-[venus-F40-mCherry].STOP VTS-term
438 pLPCXmod + metavinculin-[venus-F40-mCherry].STOP MTS-term
441 pLPCXmod + vinculin(head)-venus.STOP VHV
442 pLPCXmod + vinculin(head)-mCherry.STOP VHC
443 pBSK + vinculin-TagBFP.STOP
444 pBSK + metavinculin-TagBFP.STOP
445 pLPCXmod + vinculin-TagBFP.STOP VB
446 pLPCXmod + metavinculin-TagBFP.STOP MB
447 pBSK-∆N + vinculin(head)-[YPet(short)-HP35-
mCherry].STOP
448 pBSK-∆N + vinculin(head)-[YPet(short)-HP35-mCherry]
(NoStop)
449 pLPCXmod + vinculin(head)-[YPet(short)-HP35-
mCherry].STOP
VHTS-villin
450 pLPCXmod + vinculin-[YPet(short)-HP35-mCherry] (inter-
nal)
VTS-villin
451 pLPCXmod + metavinculin-[YPet(short)-HP35-mCherry]
(internal)
MTS-villin
655 pLPCXmod + metavinculin (DDY947NTL)-[Venus-F40-
mCherry] (internal)
MTS-CapG
674 pLPCXmod + metavinculin (DDY947DDA)-[Venus-F40-
mCherry] (internal)
MTS-DDA
675 pLPCXmod + metavinculin (DDY947DDE)-[Venus-F40-
mCherry] (internal)
MTS-DDE
676 pLPCXmod + metavinculin (DDY947DDF)-[Venus-F40-
mCherry] (internal)
MTS-DDF
677 pLPCXmod + metavinculin (DDY947DDA)-Venus.STOP MV-DDA
678 pLPCXmod + metavinculin (DDY947DDE)-Venus.STOP MV-DDE
679 pLPCXmod + metavinculin (DDY947DDF)-Venus.STOP MV-DDF
680 pLPCXmod + vinculin (I997A)-[Venus-F40-mCherry] (inter-
nal)
VTS-I997A
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mechanotransduction
cell mechanics
description of biophysical properties of a cell (e.g. elastic modulus, microrheological proper-
ties, mechanics of the cytoskeleton)
mechanotransduction (according to nature.com/subjects/mechanotransduction)
processes through which cells sense and respond to mechanical stimuli by converting them
to biochemical signals that elicit specific cellular responses
active mechanotransduction (or inside-out signalling)
generation of traction forces to probe mechanical properties of the environment
passive mechanotransduction (or outside-in signalling)
detection of external forces and transduction into the cell
mechanotransducer (or molecular force-transmitter, mechano-coupler)
protein which is under mechanical load and directly transmits forces
mechanosensing [12]
the ability of a cell or tissue to detect the imposition of a force
mechanosensor
protein which changes its conformation, binding affinity or post-translational modification
due to a direct mechanical stimulus
molecular strain gauge [13]
protein which unfurls binding domains for other proteins or singaling molecules upon force
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mechanical signaling
signal transduction pathways which are activated by mechanical stimuli
rigidity sensing
change of cell morphology, migration or activation of signaling pathways in response to
changes in substrate stiffness
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Abbreviations
aa amino acids
Abl Abelson
ABS actin binding site
AFM atomic force microscopy
AHF AHF Analysentechnik
APS ammonium persulfate
ARL actin regulatory layer
AS activation sensor
ATP adenosine triphosphate
BCA bicinchoninic acid
bis-AA bis-acrylamide
BSA bovine serum albumin
CaCl2 calcium chloride
CapG gelsolin like capping actin protein
Cat. No. Catalogue Number
cDNA complementary deoxyribonucleotide acid (DNA)
CIP calf-intestinal-phosphatase
CMV cytomegalovirus
CO2 carbon dioxide
DCM dilated cardiomyopathy
ddH2O Milli-Q filtered water
dH2O distilled water
DMEM Dulbecco’s Modified Eagle Medium
DMSO dimethylsulfoxide
DNA deoxyribonucleotide acid
dNTP deoxy nucleotide triposphate
dsDNA double stranded DNA
DTT dithiothreitol
111
Abbreviations
E.Coli Escherichia Coli
EBFP enhanced blue fluorescent protein
ECM extracellular matrix
EDTA ethlyenediaminetetraacetic acid
EM electron microscopy
ESS elastic soft substrates
ethidium bromide 3,8-diamino-5-ethyl-6-phenylphenanthridiniumbromid
EtOH ethanol
F40 flagelliform peptide
FA focal adhesion
FACS fluorescence-activated cell sorting
FAK focal adhesion kinase
FBS fetal bovine serum
FERM 4.1 protein, ezrin, radixin, moesin
FFT Fast Fourier transform
FLIM fluorescence lifetime imaging microscopy
FN fibronectin
FPGA field programmable gate array
FRAP fluorescence recovery after photobleaching
FRET Förster resonance energy transfer
FTL force transduction layer
FTTC Fourier transform traction cytometry
FX focal complex
GFP green fluorescent protein
GUI graphical user interface
HA human influenza hemagglutinin
HBS Hepes buffered saline
HCM hypertrophic cardiomyopathy
HEK 293 human embryonic kidney 293
Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HP35 villin headpiece peptide
HTI head-tail interaction
HyD hybrid detector
IF immunofluorescence
ILK integrin-linked kinase
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Abbreviations
IpaA Shigella invasin
iPALM interferometric photoactivation localization microscopy
IPTG isopropyl-β-D-thiogalactopyranosid
IRF instrument response function
ISL integrin signaling layer
KCl potassium chloride
LB lysogeny broth
LBamp lysogeny broth (LB) with 50 µgml ampicillin
Llph protein LLP homolog
LSM laser scanning microscope
MAS metavinculin activation sensor
MB metavinculin-enhanced blue fluorescent protein (EBFP)
MC metavinculin-mCherry
mCherry monomeric Cherry
MCi metavinculin-mCherry(internal)
MCS multiple cloning site
MEF mouse embronyic fibroblast
MPI Max Planck Institute
MTS metavinculin tension sensor
MV metavinculin-venus
MVi metavinculin-venus(internal)
MVt metavinculin tail domain
Na2HPO2 × 2 H2O disodium hydrogen phosphate dihydrate
NaCl sodium chloride
NEB New England Biolabs GmbH
o/n overnight
OD optical density
PAA polyacrylamide
PBS phosphate buffered saline
pBSK pBlueskript
PCR Polymerase Chain Reaction
PDMS polydimethylsiloxane
PEG polyethylenglycol
PFA paraformaldehyde
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Abbreviations
PIP2 phosphatidylinositol 4,5-bisphosphate
PIV particle image velocimetry
PKCα protein kinase C alpha
PLL poly-L-lysine
pLPCXmod modified pLPCX
PMSF phenylmethylsulfonyl fluoride
PMT photomultiplier
pN piconewton (10−12N)
PTB phosphotyrosine binding
PVDF polyvinylidene difluoride
ROCK Rho-associated protein kinase
ROI region of interest
RT room temperature
s/p streptomycin/penicillin
SDS sodium dodecyl sulfate
SDS-PAGE sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis
SEM standard error of the mean
SMC smooth muscle cell
SMC-1A structural maintenance of chromosomes 1A
TAE tris-acetic acid-EDTA
TB terabyte
TBS tris buffered saline
TBS-T tris buffered saline (TBS) polysorbate 20 (Tween20)
TCSPC time-correlated single photon counting
TDC time-to-digital converter
TEMED N,N,N’,N’-tetramethylethylenediamine
TFM traction force microscopy
TIRF total internal reflection microscopy
Tris 2-Amino-2-hydroxymethyl-propane-1,3-diol
TS tension sensor
Tween20 polysorbate 20
UV ultraviolet
VAS vinculin activation sensor
VASP vasodilator-stimulated phosphoprotein
VB vinculin-EBFP
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Abbreviations
VBS vinculin binding site
VC vinculin-mCherry
VCi vinculin-mCherry(internal)
Vh vinculin head domain
VHC vinculin-head-mCherry
VHTS vinculin head tension sensor
VHV vinculin-head-venus
Vt vinculin tail domain
VTS vinculin tension sensor
VV vinculin-venus
VVi vinculin-venus(internal)
w/o without
WB western blot
WLC worm-like chain
WLL white light laser
YFP yellow fluorescent protein
YPet(s) genetically truncated version of yellow fluorescent protein (YFP)
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